The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations by Ezuruike, UF & Prieto, JM
 Ezuruike, UF and Prieto, JM
 The use of plants in the traditional management of diabetes in Nigeria: 
Pharmacological and toxicological considerations
http://researchonline.ljmu.ac.uk/id/eprint/13622/
Article
LJMU has developed LJMU Research Online for users to access the research output of the 
University more effectively. Copyright © and Moral Rights for the papers on this site are retained by 
the individual authors and/or other copyright owners. Users may download and/or print one copy of 
any article(s) in LJMU Research Online to facilitate their private study or for non-commercial research. 
You may not engage in further distribution of the material or use it for any profit-making activities or 
any commercial gain.
The version presented here may differ from the published version or from the version of the record. 
Please see the repository URL above for details on accessing the published version and note that 
access may require a subscription. 
For more information please contact researchonline@ljmu.ac.uk
http://researchonline.ljmu.ac.uk/
Citation (please note it is advisable to refer to the publisher’s version if you 
intend to cite from this work) 
Ezuruike, UF and Prieto, JM (2014) The use of plants in the traditional 
management of diabetes in Nigeria: Pharmacological and toxicological 




The use of plants in the traditional management of diabetes in Nigeria:
Pharmacological and toxicological considerations
Udoamaka F. Ezuruike n, Jose M. Prieto 1
Center for Pharmacognosy and Phytotherapy, Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, 29-39
Brunswick Square, WC1N 1AX London, United Kingdom
a r t i c l e i n f o
Article history:
Received 15 November 2013
Received in revised form
26 May 2014
Accepted 26 May 2014






WHO Traditional Medicine Strategy
a b s t r a c t
Ethnopharmacological relevance: The prevalence of diabetes is on a steady increase worldwide and it is
now identified as one of the main threats to human health in the 21st century. In Nigeria, the use of
herbal medicine alone or alongside prescription drugs for its management is quite common. We hereby
carry out a review of medicinal plants traditionally used for diabetes management in Nigeria. Based on
the available evidence on the species' pharmacology and safety, we highlight ways in which their
therapeutic potential can be properly harnessed for possible integration into the country's healthcare
system.
Materials and methods: Ethnobotanical information was obtained from a literature search of electronic
databases such as Google Scholar, Pubmed and Scopus up to 2013 for publications on medicinal plants
used in diabetes management, in which the place of use and/or sample collection was identified as
Nigeria. ‘Diabetes’ and ‘Nigeria’ were used as keywords for the primary searches; and then ‘Plant name –
accepted or synonyms’, ‘Constituents’, ‘Drug interaction’ and/or ‘Toxicity’ for the secondary searches.
Results: The hypoglycemic effect of over a hundred out of the 115 plants reviewed in this paper is backed
by preclinical experimental evidence, either in vivo or in vitro. One-third of the plants have been studied
for their mechanism of action, while isolation of the bioactive constituent(s) has been accomplished for
twenty three plants.
Some plants showed specific organ toxicity, mostly nephrotoxic or hepatotoxic, with direct effects on the
levels of some liver function enzymes. Twenty eight plants have been identified as in vitro modulators
of P-glycoprotein and/or one or more of the cytochrome P450 enzymes, while eleven plants altered the levels
of phase 2 metabolic enzymes, chiefly glutathione, with the potential to alter the pharmacokinetics of
co-administered drugs.
Conclusion: This review, therefore, provides a useful resource to enable a thorough assessment of the profile
of plants used in diabetes management so as to ensure a more rational use. By anticipating potential toxicities
or possible herb–drug interactions, significant risks which would otherwise represent a burden on the
country's healthcare system can be avoided.
& 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
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1. Introduction
1.1. Diabetes
Diabetes is a chronic metabolic disorder characterized by high
blood glucose levels. This is either as a result of insufficient
endogenous insulin production by the pancreatic beta cells (other-
wise known as type-1 diabetes); or impaired insulin secretion
and/or action (type-2 diabetes). type-1 diabetes is an autoimmune
disease characterized by T-cell mediated destruction of the pan-
creatic beta cells. In type-2 diabetes, there is a gradual develop-
ment of insulin resistance and beta cell dysfunction, strongly
associated with obesity and a sedentary lifestyle (Zimmet et al.,
2001). Due to a higher incidence of the risk factors, the prevalence
of diabetes is increasing worldwide, but more evidently in devel-
oping countries. Current estimates indicate a 69% increase in the
number of adults that would be affected by the disease between
2010 and 2030, compared to 20% for developed countries (Shaw
et al., 2010).
Administration of exogenous insulin is the treatment for all
type-1 diabetic patients and for some type-2 patients who do not
achieve adequate blood glucose control with oral hypoglycemic
drugs. Current drugs used in diabetes management can be cate-
gorized into three groups. Drugs in the first group increase
endogenous insulin availability. These include the sulphonylureas
such as glibenclamide, the glinides, insulin analogs, glucagon-like
peptide 1 (GLP-1) agonists and dipeptidyl peptidase-IV (DPP-IV)
inhibitors. The first two members of this group act on the
sulfonylurea receptor in the pancreas to promote insulin secretion.
GLP-1 agonists and DPP-IV inhibitors on the other hand act on the
ileal cells of the small intestine. The second group of drugs
enhance the sensitivity of insulin. This includes the thiazolidine-
diones, which are agonists of the peroxisome proliferator-
activated receptor gamma (PPARγ) and the biguanide metformin.
The third group comprises the α-glucosidase inhibitors such as
acarbose, which reduce the digestion of polysaccharides and their
bioavailability (Chehade and Mooradian, 2000; Sheehan, 2003).
All the existing therapies however have limited efficacy, limited
tolerability and/or significant mechanism based side effects
(Moller 2001; Rotenstein et al., 2012).
Despite the existing pharmacotherapy, it is still difficult to
attain adequate glycemic control amongst many diabetic patients
due to the progressive decline in β-cell function (Wallace and
Matthews, 2000). In Nigeria, polytherapy with two or more
hypoglycemic agents to achieve better glucose control is common
practice (Yusuff et al., 2008). There is also a high incidence of
diabetic complications and hyperglycemic emergencies (Gill et al.,
2009; Ogbera et al., 2007, 2009). In the presence of these, the
number of prescribed drugs increases to an average of four per day
for each patient (Enwere et al., 2006). This need for the chronic
intake of a large number of drugs with their attendant side effects
in addition to their high costs which is often borne by the patients
themselves is the identified reason for non-adherence to therapy
amongst diabetic patients. As a result, patients often have recourse
to alternative forms of therapy such as herbal medicines (Yusuff
et al., 2008).
1.2. Traditional herbal medicines in diabetes management
A number of reviews on medicinal plants used in the manage-
ment of diabetes in different parts of the world (Bailey and Day,
1989; Marles and Farnsworth, 1995), as well as those used
specifically in certain regions, such as in West Africa (Bever,
1980), Central America (Andrade-Cetto and Heinrich, 2005) and
Asia (Grover et al., 2002) exist. These reviews have highlighted the
dependence of a large percentage of the world population on
traditional medicine for diabetes management. This is also corro-
borated by the WHO fact sheet (No. 134), which estimates that
about 80% of the population in African and Asian countries rely on
traditional medicine for their primary healthcare (WHO, 2008).
It also recognizes traditional medicine as ‘an accessible, affordable
and culturally acceptable form of healthcare trusted by large
numbers of people, which stands out as a way of coping with
the relentless rise of chronic non-communicable diseases in the
midst of soaring health-care costs and nearly universal austerity’
(WHO, 2013).
Ethnobotanical surveys of plants traditionally used in diabetes
management in different parts of Nigeria have been carried out
(Abo et al., 2008; Etuk and Mohammed, 2009; Gbolade, 2009;
Soladoye et al., 2012). These medicinal plants are used either alone
as a primary therapeutic choice, or in conjunction with conven-
tional medicines. On an average, approximately 50% of diabetic
patients visiting hospitals in urban cities like Lagos and Benin have
used some forms of traditional medicine during the course of their
disease management (unpublished results of field work conducted
by first author). Unfortunately, clinicians are either unaware of
their patients' herb use or the identity of the herbal product being
taken. To complicate matters further, herbal practitioners are
usually unwilling to divulge the identity of the constituents of
their preparations to patients. Most patients are also not interested
in finding this out as they consider herbal preparations to be
‘safe’; thereby making it difficult to ascertain if the herb may have
a significant contributory role to the efficacy or failure of the
treatment.
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In a systematic review of herbs and supplements clinically used
for glycemic control, Allium sativum, Aloe vera and Momordica
charantia were the only identified plants used in Nigeria.
This inclusion was however based on clinical studies carried out
outside Nigeria (Yeh et al., 2003). This indicates the lack of
information about the clinical use (or monitoring thereof) of
plants in diabetes management in Nigeria, despite widespread
traditional use.
In line with the increasing importance of traditional medicine
in various healthcare systems around the world, the WHO Tradi-
tional Medicine Strategy has recently been updated. ‘The goals of
the strategy for the next decade (2014–2023) are to support
Member States in (a) harnessing the potential contribution of
traditional medicine to health, wellness and people-centered
health-care; and (b) promoting the safe and effective use of
traditional medicine by regulating, researching and integrating
traditional medicine products, practitioners and practice into
health systems where appropriate’ (WHO, 2013).
Given that diabetes is now considered as one of the main
threats to human health in the 21st century (Zimmet et al., 2001),
there might be an even greater reliance by diabetic patients in
Nigeria on herbal medicines used in its management. Unfortu-
nately, pharmacological and toxicological evidences validating the
safety and efficacy of these medicinal plants are not readily
available. The objective of this paper is to collate as much as
possible, available information about medicinal plants tradition-
ally used in diabetes management in Nigeria. In doing so, we aim
to promote the rational use of these plants based on pharmaco-
logical evidence for their therapeutic use and their toxic/interac-
tion profile.
2. Ethno-pharmacological data collection
2.1. Method
Information about medicinal plants traditionally used in the
management of diabetes in Nigeria was obtained from published
papers and texts on ethnobotanical studies, as well as those
investigating the effect of plant(s) used in diabetes management,
in which the place of use and/or sample collection was identified
as Nigeria. A literature search of electronic databases such
as Google Scholar, Pubmed and Scopus up to 2013 was carried
out using ‘Diabetes’ and ‘Nigeria’ as keywords for the primary
searches; and then ‘Plant name – accepted or synonyms’,
‘Constituents’, ‘Drug interaction’ and/or ‘Toxicity’ for the secondary
searches.
In order to highlight medicinal plants traditionally used in
diabetes management with the potential for integration into the
healthcare system, not all identified plants were included in this
paper. Only those with (1) more than one reference to its use in
diabetes management in Nigeria based on ethnobotanical studies
were retained; and/or (2) experimental evidence in one or more
diabetes experimental models validating its activity. This review is
therefore not exhaustive for all the plants used traditionally for
diabetes management in Nigeria.
2.2. Results
Data for one hundred and fifteen plants traditionally used in
diabetes management in Nigeria were obtained, either from previ-
ously conducted ethnobotanical studies (Abo et al., 2008; Aiyeloja
and Bello, 2006; Ajibesin et al., 2008; Etuk and Mohammed, 2009;
Gbolade, 2009; Igoli et al., 2005; Lawal et al., 2010; Ogbonnia and
Anyakora, 2009; Okoli et al., 2007; Olowokudejo et al., 2008); or
from primary research papers (as indicated in Table 1). These
are tabulated according to their accepted Latin Name (based on
http://www.plantlist.org). Synonyms are included for plants which
were not identified with their accepted names in the primary
research paper. For each of the identified plants, the family name,
common name(s), identified region of use in diabetes manage-
ment, experimental evidence of activity (where available), other
medicinal uses, plant part(s) used, traditional method(s) of pre-
paration, identified active constituent(s), other relevant phyto-
chemical constituents, as well as data on interaction and toxicity
studies are included [Table 1].
Out of the 115 plants reviewed in this paper, only twelve of
them have no experimental evaluation of their blood sugar
reducing effects, either in vivo or in vitro. In selecting studies to
be included, priority was given to investigations carried out with
samples collected in Nigeria. Certain publications were not
included if the study design of the experimental evidence
was not appropriate enough for validating the effect of the plant,
such as the absence of a suitable control or the use of improper
doses. Two-thirds of the identified plants with experi-
mental evidence for their biological activity involved samples
collected from Nigeria. For the remaining one-third, although the
studies were not carried out with plant samples sourced from
within Nigeria, these were still included, as the experimental
evidence could provide some information validating their use in
diabetes management, since they are widely used in Nigeria. The
ethnobotanical research carried out on Moringa oleifera provides a
rationale for including information from studies carried out in
different countries, as some of these locally available plants could
have been initially sourced from elsewhere (Popoola and Obembe,
2013).
In-vitro experimental studies as well as phytochemical studies
carried out on the plant species regardless of the source of
the plant samples were also included. These together could
provide more insight into the biological activity(s) of the plant,
which would in turn help to promote a more rational use
of the plant in diabetes management, either in the presence or
absence of other co-morbidities. For completeness, reports
on the antioxidant properties of many of the identified plants
have been included as this has become a popular parameter
in assessing the beneficial effects of a plant in diabetes
management.
3. Pharmacological evidence and its clinical implications
3.1. In vivo hypoglycemic activity
Reducing blood sugar level is the classical clinical target in all
forms of diabetes. Thus, the in vivo sugar lowering effect of
putative hypoglycemic plants is therefore a premise to infer their
potential clinical efficacy. In vivo validation also provides an
indication of the relative toxicity of the plant. Although most
herbal medicines have a long history of traditional use, only their
experimental validation at known doses may give a clearer idea
about its safety and efficacy, in line with the objectives of the WHO
Traditional Medicine Strategy (WHO, 2013).
Ninety six out of the one hundred and fifteen plants here
reviewed have been evaluated in various in vivo animal models
of diabetes, mostly using alloxan and/or streptozotocin (STZ)-
induced diabetic animals, which are the most frequently used
animal diabetes models worldwide (Fröde and Medeiros, 2008).
These chemical agents are cytotoxic to the β-cells of the pancreatic
islets, generating a state of insulin deficiency (akin to type-1
diabetes) with subsequent hyperglycemia (Szkudelski, 2001). The
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Table 1
Medicinal plants used in the management of diabetes in Nigeria.
S/
no.









its use in diabetes
management




















SW, SS 100 and 200 mg/kg of the
seed and peel powder
decreased blood glucose in
STZ induced diabetic rats
(Sabitha et al., 2011)§;
Antioxidant effects of the
aqueous extract of the leaves



























of the fruits decreased
oral metformin
absorption in-vivo












SW Inhibited α-amylase and α-
glucosidase enzymes and
antioxidant effects (Vadivel
et al., 2011); 100 and 200 mg/
kg aqueous extract of the
seeds produced a dose
























Caffeic acid (Vadivel et al.,
2011); Abruquinones (Kuo
et al., 1995); Abrusosides
(Choi et al., 1989);
Trigonelline, Hypaphorine,
Precatorine, Abrine
(Ghosal and Dutta, 1971)
Abrin-Toxic component





Bagaruwa (H) NC 50 mg/kg of the ethyl acetate
fraction of the methanol




diabetic rats than the













Catechin and gallic acid
derivatives (Malan, 1991);
Androstene steroid
(Chaubal et al., 2003); D-




et al., 2010); Lupenone,
Acanilol A and B (Ahmadu
et al., 2010)
Co-incubation of 0.01%
of the extract in Caco-2
cell monolayers
decreased the integrity













NE, SW 100 mg/kg of the methanol
extract of the stem bark
decreased blood glucose
levels by 51% in STZ-induced

































SW Inhibitory effects on α-
amylase and α-glucosidase
enzymes, Antioxidant
activity (Adefegha and Oboh,
2012)
200 & 400mg/kg aqueous


















Inhibition of Cyp 3A4,
3A5 and 3A7 enzyme
activity (Agbonon et al.,
2010); Elevated levels of
liver function enzymes
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identified in the plant
Interaction/toxicity
studies








SW, NC 100, 200 and 300 mg/kg of
the aqueous extract of the
leaves decreased blood
glucose levels in both normal
rats, STZ-induced diabetic
rats and glucose-loaded rats
(Nyunai et al., 2009)§; 100,
200 and 400 mg/kg of the
ethanol extract of the shoot
decreased blood glucose
levels in normal and alloxan
induced diabetic rats





































SE, SW, SS Antioxidant activity and
hepatoprotective effects
(Olaleye and Rocha, 2007,
2008); Significant decrease in
blood glucose levels in STZ-
induced diabetic rats
administered 200, 400 and
800 mg/kg of the n-butanol
fraction of the aqueous
extract of the leaves












Decoction Alchornoic acid (Kleiman
et al., 1977); Quercetin and
its glycosides, Gallic acid,
Triisopentenyl guanidine,
Protocatechuic acid
(Lamikanra et al., 1990);
Ellagic acid (Banzouzi et










8 Allium cepa L. Amaryllidaceae Onion Alubosa (Y) SE 100 and 300 mg/kg aqueous
extract of the bulb
administered for 30 days
decreased blood glucose
levels in alloxan-induced
diabetic rabbits and restored
decreased levels of
antioxidant enzymes



























9 Allium sativum L. Amaryllidaceae Garlic Aayu (Y),
Ayo-ishi (I),
Tafarunua (H)
SS, SE 200–300 mg/kg aqueous
extract of the cloves
decreased blood glucose
levels in alloxan-induced
diabetis rats after one week
(Eyo et al., 2011); 250 and
500 mg/kg ethanol extract of
the cloves administered for
14 days produced a dose-
dependent decrease in serum













(Sheela et al., 1995)
S-allylcysteine sulfoxide
(SACS), Allyl sulfides,
Allicin and its breakdown
products, Allixin,
Eruboside B, Vitamin B6
and B12 (Corzo-Martínez











2006); and in humans
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its use in diabetes
management









identified in the plant
Interaction/toxicity
studies
function enzyme levels and
increased serum insulin
levels in STZ-induced




10 Aloe vera (L.)
Burm.f.
Asparagaceae Barbados aloe Ahon erin (Y) SE 150 mg/kg of the dried pulp
extract/exudate administered
to STZ-induced diabetic rats
decreased fasting blood
glucose levels and improved
the levels of the antioxidant
enzyme (Nwanjo, 2006);
1 mg/ml aloe vera whole gel
extract prevented the onset
of hyperglycaemia in alloxan-
induced diabetic rabbits
(Akinmoladun and Akinloye,
2007); 350 mg/kg of a
polyphenol-rich gel extract
administered to insulin
resistant mice for 4 weeks
improved insulin tolerance
and fasting blood glucose






Leaves Juice extract Mannose-6-phosphate,
Barbaloin, Emodin, Aloin,
Aloe emodin, Aloesin, β-
sitosterol, Diethylhexyl
phthalate (Choi and
Chung, 2003); Aloetic acid,
































SWc In vitro antioxidant effects













1984); α-amyrin and its
esters, Lupeol and its













SW Administration of 1 g/kg of a
1:1 mixture of a
hydroethanolic extract of
Alstonia congensis bark and
Xylopia aethiopica fruits
decreased blood glucose
levels in normal mice
(Ogbonnia et al., 2008a);
In vitro antioxidant effects











Akuammicine and its 12-
Methoxy derivative,
Tubotaiwine, 12-methoxy
tubotaiwine and its 12-
methoxy derivative,
Akuammidine,
Angustilobine A and B,
Seco angustilobine A and
B, Anugustilobine-B-N-








Anacardiaceae Cashew Kasu (Y),
Sashu (I),
Kanju (H)
SW, NC Stimulated glucose uptake in
C2C12 myoblasts and rat liver
mitochondria (Tedong et al.,
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identified in the plant
Interaction/toxicity
studies
extract of the stem bark
administered to rats
alongside a high-fructose
diet prevented the onset of
hyperglycaemia (Olatunji et
al., 2005); 100–800 mg/kg
aqueous and methanol
extract of the stem bark
decreased blood glucose
levels in both fasted normal








et al., 1993); Stigmast-4-
en-3-ol and Stigmast-4-
en-3-one (Alexander-
Lindo et al., 2004); Lutein,
β-carotene, Zeaxanthin, α-
tocopherol, γ-tocopherol,
Thiamin, Stearic acid, Oleic
acid and Linoleic acid
(Trox et al., 2010)
14 Ananas comosus
(L.) Merr.
Bromeliaceae Pineapple Ogede oyinbo
(I)
SW The ethanolic extract at a
dose of 400 mg/kg improved
insulin sensitivity in diabetic
dyslipidaemic rats; as well as
improved glucose uptake in
insulin resistant HepG2 cells
(Xie et al., 2006)§
Inflammation, Anti-
parasitic







Ananaflavoside B and C,
Ananasate, Dicaffeoyl
glycerides, Tricin, Feruloyl










diabetic mice (Manosroi et
al., 2011); Antioxidant effect
(Aliyu et al., 2010); 100–
400 mg/kg of the aqueous
stem extract decreased blood


























extract of the leaves inhibits
α-amylase and α-glucosidase
enzymes, but less potent
































(Fournier et al., 1999);
Gallic acid, Epicatechin,
Quercetin and its
Chronic intake of the
fruit and infusions of
the plant is thought to
bring about
neurodegeneration in
the CNS; attributed to
coreximine and
reticuline alkaloids
present in the plant
(Lannuzel et al., 2002),
as well as the
acetogenin annonacin
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100 mg/kg of the aqueous
extract of a herbal
preparation ADD-199
containing the roots of
Annona senegalesis and three
other plants decreased
plasma glucose and increased
plasma insulin in STZ-
induced diabetic mice; as
well as increased glucose
uptake by isolated
diaphragm (Okine et al.,
2005)§; Antioxidant effects










Zafra-Polo et al., 1998);
Roemerine, Isocorydine,
8,8-Bisdihydrosiringenin,





(Leboeuf et al., 1980);
Rutin, Epicatechin,
Catechin, Isoquercetin










et al., 2012); Roemerine
interacts with P-gp and
enhances vinblastine
cytotoxicity (You et al.,
1995); ADD-199 did not
interact with Cyt P-450
isozymes nor produce
ay organ toxicity














(Atawodi et al., 2011);
200 mg/kg aqueous extract
decreased blood glucose
levels after 2 h in alloxan-






Stem-bark Decoction Castalagin, Ellagic acid,
Flavogallonic acid
(Shuaibu et al., 2008);
Leiocarpan A and B
(Aspinall et al., 1969);
Gallic acid, Chlorogenic
acid, Protocatechuic acid
P-comaric acid (Kone et
al., 2012)
Dose-dependent
toxicity of the aqueous
leaf extract in rat lungs
characterised by
inflammation and











r111 mg/kg ethanolic root
extract decreased blood
glucose levels in alloxan-
induced diabetic rats
(Okokon et al., 2012); Alpha
amylase inhibitory effects of
the hydro-alcoholic extract of
the leaves and stem bark as
well as hypoglycaemic effect
of 1 g/kg of the stem bark in
alloxan-induced diabetic rats














(Tchacondo et al., 2011)
20 Anthocleista
vogelii Planch.
Gentianaceae Cabbage tree Kwari (H),
Opa oro (Y)
NC, SW Hypoglycaemic effect of 100–
800 mg/kg aqueous extract in
normal and alloxan-induced
rodents (Abuh et al., 1990);
Hydro-alcoholic extract of
the leaves and stem bark
produced o50% alpha
amylase inhibitory effects
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Aristolone (Lajide et al.,
1993); Aristolochic acids I,


















Decoction Aristolochic acid I and II,
Aristolactam A (Kumar et
al., 2003); Magnoflorine




Risk of AAN (Heinrich et
al., 2009); Chronic
dosing of goats with the
aqueous leaf extract
resulted in toxic effects
culminating in death
(Barakati et al., 1983)
23 Aristolochia
repens Mill.
Aristolochiaceae Akoigun (Y) SW, SS Hemorrhoids,
Rheumatism,
Aphrodisiac
Stem bark Decoction Aristolochic acids I, II, IV, C
and D, Aristolochic acid D-
beta-D-glucoside,
Aristolactam I-beta-D-
glucoside (Michl et al.,
2011)









SS, SW 25 mg/ml ethanolic leaf
extract increased insulin
release from the pancreas
(Chattopadhyay, 1999)§;
400 mg/kg hydro-ethanolic
extract of the leaves
decreased blood glucose in
alloxan-induced diabetic rats,
and produced a synergistic
effect with Vernonia
amygdalina (Ebong et al.,
2008); 500 mg/kg ethanol
extract of the leaves
decreased blood glucose
levels and improved
pancreatic lesions in STZ-
induced diabetic rats



























GIIIa, GIb (Biswas et al.,
2002)
Various pharmaco-toxic
effects were seen with
Neem oil with an LD50






margin of safety when
used therapeutically.






Abafe (Y) NW, SW Antioxidant effects (Argolo et
al., 2004); 1 g/kg stem bark
extract decreased blood
glucose levels in alloxan-
induced and glucose loaded


























quercetin (Menezes et al.,
2007); BmoRoL and










2011); 500 mg/kg aqueous
extract of the leaves
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well as improved serum lipid
profile in alloxan-induced


















diterpenes (Martin et al.,
1997); Griffonilide,
Rhamnetin, Carotenoids
(Okwute et al., 1986)
of the monolayer and
the secretory transport
of Cyclosporin A (CsA)
indicating possible
inhibition of P-gp










(Aderogba et al., 2008);
500 mg/kg ethanol root
extract decreased blood
glucose in both normal
glucose-loaded rats and
alloxan induced diabetic rats





















NW, NE Antioxidant effects (Aliyu et
al., 2009; Compaoré et al.,
2011); Dose dependent (200–
400 mg/kg) decrease in blood
glucose levels by methanol
extract of the leaves in
alloxan-induced diabetic rats











(Compaoré et al., 2011);
Benzopyrandiol and triol
derivatives (Maillard et al.,
1991)







decreased blood gucose in
C57BL/Ks-db/db mice, a type






























Gallic acid, Salicylic acid,
Protocatechuic acid,
P-coumaric acid, Ferulic













Centaurein (Lima Silva et
al., 2011)







NE, SW, SE 80 mg/kg of the seed coat
extract decreased blood
glucose levels and increased
plasma insulin levels and




















acetone (Gutierrez et al.,
2011); β-tocopherol,
Vitamin E (Ponnusamy et
The carotenoid Bixin,
isolated from the seed
coat extract has been
shown to induce Cyt
P450 enzymes in the
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identified in the plant
Interaction/toxicity
studies
(Russell et al., 2005)§;
Methanol extract of the
leaves (49 μg/ml) produced
inhibitory effects against
human pancreatic amylase




Ishwarane, Phytol (Raga et
al., 2011); Capric, Palmitic,
Stearic, Oleic and Linoleic
acids (Silva et al., 2008);
Gallic acid, Pyrogarrol,
Isoscutellarein (Terashima




1999); Bixin as well as
other constituents of
annato dye from the
seed extract play an
important role in the
induction of Cyp 1A and
2B enzymes in rats (De-
Oliveira et al., 2003);
Seed constituents have
also been found to
possess opposing
hyperglycaemic effects
(Fernandes et al., 2002;
Gutierrez et al., 2011)








SW, NC Aqueous root bark extract
(100 and 200 mg/kg)
















mice but not cats,
dogs and pigeons
with lethality at
doses 450 mg and
150 mg/kg for
hypoglycin A and B
respectively in mice
(Chen et al., 1957)
Hypoglycin A, Hypoglycin

















effect can lead to death
due to severe fatty acid
degeneration and
glycogenolysis (Hassall








SW, SE 100 and 200 mg/kg aqueous
and methanol extracts of the
leaves decreased blood
glucose levels in normal rats
and alloxan-induced rats
when pre-treated; Also daily
intake of 15 mg of the extract
as an infusion lowered blood
glucose levels of type-2
diabetic patients in a clinical
study (Iwu, 1983); Radical
scavenging effects (Cimanga
et al., 2001); Administration
of 250 mg/kg ethanol extract
of the root for 4 weeks
improved glucose tolerance
in high-fructose fed Wistar












































Rh-123 efflux in Caco-2
cells (Ezuruike et al.,
2012); No observed
acute or chronic toxicity
in rats after 6 months
intake or high doses up
to 5 g/kg. However

















SW, SE 250 mg/kg of the methanol
extract of the leaves
decreased blood glucose in
alloxan-induced diabetic rats
and produced good







Decoction Delphinidin, Gallic acid,
Caffeic acid, Ellagic acid,
Friedelin, Epifriedelinol
Taraxerol, Taraxerone
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SW 400 mg/kg of the aqueous
extract of the fresh leaves
produced hypoglycaemia in




500 mg/kg aqueous extract of
the leaves in normal fasted
glucose-loaded and STZ-
induced diabetic rats
(Ogbonnia et al., 2008c);
In vitro antioxidant effects

























glycosides, α- and β-
amyrin and their acetates,
Glutinol, Bryophollone,
Bryophynol, Bryophyllol,
Bryophyllin A and B,





dienol (Afzal et al., 2012)
Risk of cardiac glycoside
poisoning due to the
bufadienolides
Bryotoxin A, B, C
(McKenzie et al., 1987);
Significant decrease in
serum ALT levels in rats
after daily oral dosing of
2 g/kg aqueous extract













SW, NW 400 mg/kg dried latex




antioxidant effects (Roy et al.,
2005)§; 250 mg/kg of
different solvent extracts of
the root decreased blood
glucose levels in STZ-induced
diabetic rats (Bhaskar and
Ajay, 2009)§; Antioxidant















































(Ibrahim et al., 2012); CP-P
(Apolipoprotein A-1)
(Samy et al., 2012)
Cardenolides present in






of the plant are being
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SW, SE Alpha glucosidase and α-
amylase inhibitory activities
and antioxidant effects (Oboh
et al., 2011; Kwon et al.,
2007); Incorporation of 2% of
the fruit powder in a high fat
diet given to STZ-induced
diabetic rats increased serum
insulin levels (Islam and
Choi, 2008)§; 100 mg/l fruit
extracts possessed PPAR
alpha and gamma agonistic


















diene octadecamide, 9, 12-
diene-octadecanoic acid
(Dastagir et al., 2012);
Capsianocide VIII, IX, L, III,







Marino et al., 2006)







100–400 mg/kg of the
aqueous seed extract
decreased blood glucose and
improved serum lipid levels
in normal rats (Adeneye and
Olagunju, 2009); 400 mg/kg
aqueous extract of the leaves




602 g of the fruit (equivalent
to 50 g carbohydrate) to type
2 diabetic patients produced
an increase in serum insulin
levels in the patients (Fatema
et al., 2003)§; Antioxidant
effects of different parts of


































(Canini et al., 2007);
Papain, Chymopapain A, B
and C, Peptidase A and B,
Lysozyme, Carpasamine,




(Krishna et al., 2008)











as it increased the INR
of a patient (Shaw et al.,
1997); Aqueous extract
of the leaves inhibited
P-gp efflux activity in
Caco-2 cells (Oga et al.,
2012)




Aidantoro (Y) SW In vitro antioxidant effects
(Luximon-Ramma et al.,
2002; Manonmani et al.,
2005); Hexane extract of the
stem bark produced a dose
dependent decrease in
alloxan-induced diabetic rats
(Nirmala et al., 2008);
Ethanol and ethyl acetate
extract of the bark decreased
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fatty acids, Biochanin A,
Phytol, Lectins CSL-1.


















In vitro antioxidant effects










Decoction Epiafzelechin (Kpegba et
al., 2011); Myricetin and
Quercetin 3-O-





Traditional use of the
plant is associated with
GIT side effects (Maiga
et al., 2005); Liver and
kidney toxicities of
aqueous extracts of
various parts of the
plant (Toma et al., 2009;













SE, NC Administration of 600 mg/kg
methanol extract of the stem
bark to alloxan-induced
diabetic mice decreased
blood glucose levels by 46.8%
(Ezeigbo and Asuzu, 2010)
In vitro antioxidant effects
































Stigmasterol and their D-
glucosides (Chang et al.,
1998); Isorhamnetin,
250 mg/kg aqueous
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250 mg/kg methanol extract
of the leaves decreased blood
glucose levels in alloxan-
induced diabetic rats and
increased the hypoglycaemic
effect of metformin but not
glibenclamide (Ohadoma and
Michael 2011); Juice extract
of the fresh leaves of the
plant gave a dose dependent
(0.5–1 ml/kg) decrease in
blood glucose levels in
normal and alloxan-induced
diabetic rats (Nammi et al.,
2003)§; 500 mg/kg dichloro-
methane methanol (1:1)
extract of the aerial parts
showed a prophylactic action
against STZ-induced
hyperglycaemia in rats and
increased the activity of
some glucose metabolizing

















(Chung et al., 2007); 3-O-
glucosides and 3-O-(6-O-
p-coumaroyl) glucosides











and Oleanolic acids (Usia












Carosine (Svoboda et al.,
1962)
Potent inhibitory effects




from the aerial parts
















SE, SW 100 and 200 mg/kg hydro-
ethanol extract of the seed
cotyledon given to alloxan-
induced diabetic mice for











Decoction Eleagnine, Anacardic acid,













SW In vitro antioxidant effects





Fruit Juice extract α- and β-pinene,
P-cymene, Limonene and
its oxide, Linalool and its
oxide, Citral, α- and β-
terpineol, Myrtenol




in citrus fruits have
been identified as
inducers and inhibitors
of Cyt P450 enzymes
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SS 875 mg of a mix of extracts of
the fruit and Rauvolfia
vomitoria foliage (RC tea)
decreased serum glucose
levels in diabetes type
2 model db/db mice and also
decreased tissue lipid
accumulation (Campbell et
al., 2006); RC tea given daily
for 4 months to type-2
diabetic patients decreased
fasting and post prandial
plasma glucose levels
especially in patients with
HbA1c levels o7.3%






































45 Citrus sinensis (L.)
Osbeck






(Guimarães et al., 2010)§;
Free and bound phenolics
extracted from the dried fruit
peel exhibited potent dose-
dependent α-amylase and α-
glucosidase inhibitory effects
(Oboh and Ademosun, 2011)













shown to induce Cyp










Baala, Egusi NW, SW Saponin fractions of aqueous
extract of the rind decreased
plasma glucose at doses
















Extracts of the plant
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rabbits (Abdel-Hassan et al.,
2000)§; Plasma glucose levels
and pancreatic β-cell mass
were restored to normal in
STZ-induced diabetic rats fed
an 8% colocynth oil diet
(Sebbagh et al., 2009)§;
Antioxidant effects (Kumar et
al., 2008)
dihydroxypropiophenone,














and its glucosdie (Maatooq
et al., 1997); Oleic,
Linoleic, Linolenic,
Arachidonic, Palmitate,
Stearic and Myristic acids

















of the fruit were co-











50 mg/kg globulin proteins
extracted from the seeds
decreased blood glucose
levels when pre-
administered to normal high
glucose fed rats (Teugwa et
al., 2013a)§; Antioxidant







(Abdelwahab et al., 2011);
Lycophene, Phytofluene,
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Malvaceae Kolanut Obi agada (Y),
Orji (I)
SW Antioxidant effects (Atawodi
et al., 2007) 500 mg/kg of the
methanol extract of the stem
bark decreased blood glucose
levels in alloxan induced
diabetic rats after 21 days











Procyanidin B1 and B2,
Catechin, Epicatechin,
Caffeine (Atawodi et al.,
2007); Theobromine











SW Methanol extract of the
leaves inhibited both α-
amylase and α-glucosidase
enzymes (Oboh et al., 2012a)
















et al., 2003); Dicaffeoyl










2009); Caffeic acid and
Isorhamnetin (Oboh et al.,
2012a)
Ethanol extract of the
aerial parts of the plant
inhibited Cyt P450 3A4
and 3A7 (Agbonon et
al., 2010)
50 Croton lobatus L. Euphorbiaceae Lobed croton,
Cascarilla
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identified in the plant
Interaction/toxicity
studies








SW 50 mg/kg of globulin proteins
extracted from the seed
when pre-administered to
high glucose fed rats did not
cause a significant decrease
in blood glucose levels
(Teugwa et al., 2013a)§;




Seed, Fruit Juice extract,
Powdered
seeds



















Decoction Piloside A and B,
Curculigoside, Curculigine,
Nyasicoside, Pilosidine
(Palazzino et al., 2000);
Β-amylase (Dicko et al.,
1999); Nyasicoside,
Pilosidine, Curculigine
(Cometa et al., 2001)
53 Curcuma longa L. Zingiberaceae Turmeric Atale pupa SW, NC Ethanol extract of the
rhizome incorporated in the
diet of type 2 diabetic KK-Ay/
Ta mice as 0.2–1 g/100 g
produced a hypoglycaemic
effect compared to control
and showed PPARγ binding
activity (Kuroda et al.,
2005)§; Antioxidant effects
(Selvam et al., 1995)§; Plasma
insulin levels of healthy
subjects were significantly
increased 2 h after ingestion
of 6g turmeric powder













turmerone (Kuroda et al.,
2005; Roth et al., 1998);
Tetrahydrocurcumin (Pari
and Murugan, 2007); α











Bisaboline (Leela et al.,
2002); Vanillin, Vanillic
acid, Ferulic acid and
Ferulic aldehyde (Appiah-
Opong et al., 2007)
Methanol extracts of
the rhizome inhibits
CYP 3A4 activity in









Opong et al., 2007);












SW, SE Aqueous extract of the leaves
produced a dose dependent
(125–500 mg/kg) decrease in
fasting plasma gucose levels
after oral administration to
normal rats for 42days
(Adeneye and Agbaje, 2007);







































Aqueous extract did not
inhibit P-gp efflux
activity in Caco-2 cells
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identified in the plant
Interaction/toxicity
studies














Leguminosae African balsam Iya (Y), Maje
(H), Ozabwa
(I)
SE, NE 100, 200 and 400 mg/kg
aqueous leaf extract
decreased blood glucose
levels in normal and alloxan-
induced diabetic mice
(Manosroi et al., 2011);
250 mg/kg aqueous extract of
a mixture of the root with
that of Sacrocephalus latifolius
for 21days decreased blood
glucose levels and increased
the activity of various glucose
metabolizing enzymes in
alloxan-induced diabetic rats












Maceration Daniellic acid, Oliveric acid
















(Schwob et al., 2008);
Narcissin, Quercimeritrin,








NE, SE, NC 200 and 400 mg/kg aqueous
bark extract decreased blood
glucose levels in normal and
alloxan-induced diabetic
mice after 3hrs (Manosroi et
al., 2011); 100 mg/kg of the
gum administered alone or







































acid (Aquino et al., 1992)
Incorporation of













SWa 100 mg/kg aqueous extract of
the leaves given for 30 days
decreased blood glucose











High doses of the
ethanol leaf extract can
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(Adewole et al., 2011); and
reversed nephrotoxic effects
of STZ (Adewole et al., 2012);
250 mg/kg aqueous extract of
the leaves in fructose-fed rats
improved glycaemic control
(Taiwo et al., 2010); α-
glucosidase & α-amylase
inhibitory effects (Kazeem et
al., 2013) Antioxidant effects








(Bafor et al., 2013); α-







Globulol (Oladosu et al.,
2009)
liver and kidneys
(Ahmed et al., 2012)
58 Ficus thonningii
Blume




Cediya (H) SW 0.5 mg/ml of the acetone
extract of the leaves
produced about 30%
inhibitory effects against α-
amylase and α-glucosidase
enzymes (Olaokun et al.,
2013); Dose dependent blood
glucose lowering effects of
the ethanol stembark extract
in STZ-induced and normal







Decoction Benzaldehyde, α- and β-
pinene, β-caryophyllene,
Zingiberene, α- and β-




(Ogunwande et al., 2008)
Possible testicular, lung
and hepatic toxicities at
doses Z500 mg/kg
(Aniagu et al., 2008)
59 Garcinia kola
Heckel-




SW, SE 100 mg/kg kolaviron
decreased blood sugar levels
in normal and alloxan
induced diabetic mice; as
well as inhibited aldose
reductase enzyme activity
(Iwu et al., 1990a);
Hypoglycaemic effect of
kolaviron is due to GB1 and




inhibitory effect of GB1


























flavanone (Iwu et al.,
1990b); Lavender lactone,













seeds by ten healthy
volunteers 30 min prior


















SE, SW, SS Ethanol extract of the leaves
decreased blood glucose
levels in STZ-induced
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100 mg/kg of the methanol
extract in alloxan-induced
diabetic mice (Ogundipe et
al., 2003)
Antioxidant effects (Fasakin
et al., 2011; Ugochukwu and
Babady, 2002)
150 ml of a (1:1:1) decoction




blood glucose levels when
preadministered to normal
subjects 45 min before an




extract of the stem
and leaves in
glucose loaded rats
as well as the
In vitro glucose
stimulating effects
in INS-1 cells led to












α- and γ-Eudesmol, (E)-
Phytol, Methyl palmitate





























NW Aqueous extract of the leaves
produced a non-significant
blood glucose lowering effect
of only 17% in alloxan-






















R. Br. Ex Sm.
Apocynaceae Cow plant SE GS4, a low MW component
of the aqueous extract of the
leaves decreased blood
glucose levels and increased
insulin release in rats, Type
1 and 2 diabetic patients
(Shanmugasundaram et al.,
1990a, 1990b; Baskaran et al.,
1990)§; The action of GS4 on
insulin release is by increased
membrane permeability
(Persaud et al., 1999)§; A high
MW extract of the leaves
OSAs increased plasma
insulin levels in-vitro and in
humans through a direct
stimulatory effect (Al-









Leaves, Roots Infusion Gymnemic acids I-XVIII,
Gymnemagenin or Genin L
and its acetate (β-amyrin
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identified in the plant
Interaction/toxicity
studies


























effects (Adejuwon et al.,
2011); An alkaloidal fraction














































Methanol extract of the
leaves decreased blood
glucose levels in alloxan-
induced diabetic rats at doses
between 250 and 1000 mg/
kg (Ezeigbo and Asuzu,
2010); Antioxidant effects





















(Pais et al., 1968)
65 Ipomoea batatas
(L.) Poir.




SW Aqueous extract of fresh
whole plants produced a
dose-dependent (100–
400 mg/kg) decrease in blood
glucose in normal and STZ-
induced diabetic rats (Olowu
et al., 2011); Daily ingestion
of 4 g by type 2 diabetic
patients for 3 mths resulted
in improved FBG and HbA1c






aqueous extract of the cortex











ellagic acid and 3,5-
dicaffeoyl quinic
acid isolated from













(Matsui et al., 2002)
Non-, Mono- and




glucosides of Cyanidin and















acid, Caffeic acid (Islam et
4-Ipomeanol produces
an irreversible
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identified in the plant
Interaction/toxicity
studies
al., 2002); Ellagic acid,
Caffeic acid, Scopoletin
and 3,5-dicaffeoyl quinic










Ogbono (I) SE, SS, SW Daily intake of a dikanut
supplemented diet (4g/day)
by type 2 diabetic patients
for 1 month resulted in
improved lipid profile and
decreased blood glucose














acid (Donfack et al., 2010);
2 g/kg administered 2 ce
daily to STZ-induced diabetic
rats decreased blood glucose,
and lactate dehydrogenase
and pyruvate kinase enzymes
(Ozolua et al., 2006)
Ellagic acid, Mono, Di and








the seed extract in a
randomized double-blinded
study had decreased blood
glucose, adiponectin, leptin
and C-reactive protein levels
and improved plasma lipid
profile compared to placebo
(Ngondi et al., 2009)§
Antioxidant effects (Donfack
et al., 2010; Awah et al., 2012)









SW Antioxidant effects (Igbinosa
et al., 2011) 250 and 500 mg/
kg of the hydro-ethanolic
extract of the leaves
decreased blood glucose
levels in alloxan-induced
diabetic rats (Mishra et al.,
2010)§ 100 mg/l ethanol
extract of the stipe showed
PPARα, γ and δ activities (Rau
et al., 2006)§ 250 and
450 mg/kg of the aqueous
extract of the roots decreased
fasting blood glucose levels
in alloxan induced diabetic

















Curcacycline A (van den
Berg et al., 1995);
Esterases, Lipase















hemorrhage of the liver,
lungs and stomach
resulting in death at
high doses in mice
(Abdu-Aguye et al.,
1986)







Jatropholones A and B,
Acetoxyjatropholone,




Administration of 10 mg
of the methanol extract
of the seeds daily to rats




Ethanol extract of the
root bark of the plant
inhibited Cyt P450 3A4
and 3A7 enzymes
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Khayanolide A and B,













(Abdelgaleil et al., 2001);
Proceranolide and its
n-butyric derivative













containing a mix of
extracts of the stem




of fat liver Cyt P450
enzymes (Martey et al.,
2009) Aqueous extract


















An extract of the bark in
buffer solution produced
moderate inhibition of α-
amylase activity in-vitro
(Funke and Melzig, 2006)
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identified in the plant
Interaction/toxicity
studies
200 mg/kg aqueous extract of
the bark produced only a 4%
decrease in blood glucose
levels after 2 h (Etuk and
Mohammed, 2009); while
the oil extract of the seeds
decreased blood glucose
levels by 20% after 2 h, which
increased to 60% after 8hrs
(Momoh and Muhammed,




(Zhang et al., 2007);
Khayanolides D and E,
Khayanoside (Nakatani et
al., 2002); Khayanolides A,
B and C, Seneganolide,
Methyl angolensate and its
6-hydroxy and 6-acetoxy
derivatives (Abdelgaleil et

































SW Alpha glucosidase inhibitory
effects of the ethanol extract
of the leaves (Prashanth et
al., 2001)§ Increased activity
of in-vivo antioxidant
enzymes (Dasgupta et al.,
2003)§ Daily administration
of graded doses (100–
800 mg/kg) of the ethanol
extract of the leaves for
2 weeks decreased blood
sugar levels in alloxan-
induced diabetic rats
(Inawati and Winarno,
2008)§ In vitro antioxidant
effects of isolated
constituents of the plant
















Leaves Decoction Lawsone and gallic
acid isolated from
the ethanol extract















(Siddiqui et al., 2003);
Isoplumbagin, Hexenol,











(Oyedeji et al., 2005);
Administration of






2 enzymes GST and DDT
(Dasgupta et al., 2003)
Topical application to
skin lesions in G6PD
deficient patients
resulted in hemolytic
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Stearic acids, Laxanthone I,











Esters of Lawnermis acid
(Chaudhary et al., 2010)
Trihydroxy acetophenone
and naphthalene gluco-




Anacardiaceae Mango Mangoro SS, SE 1 g/kg of the aqueous extract
of the leaves decreased blood
glucose levels in normal and
glucose loaded mice, but not
in STZ-induced diabetic mice
(Aderibigbe et al., 2001)
Alpha glucosidase inhibitory
effects of the ethanol extract
of the bark (Prashanth et al.,
2001)§ 200 mg/kg aqueous
extract of the leaves
decreased blood glucose
levels in alloxan-induced
diabetic rats (Etuk and
Mohammed, 2009)
Dipeptidyl peptidase IV
inhibitory activity of the





















acid, Benzoic acid, Methyl
gallate, Propyl gallate,
Mangiferin, Catechin,
Benzoic acid propyl ester
(Núñez Sellés et al., 2002)
Violaxanthin dibutyrate, β-





palmitic and myristic acid







(Schieber et al., 2003;
Berardini et al., 2005)
Stem bark extract of the
plant, mangiferin and
its metabolite
norathyriol as well as
quercetin, constituents
of the plant showed
dose-dependent
modulation of P-gp
activity in HK-2 and
Caco-2 cell lines (Chieli
et al., 2009) The stem
bark extract also
showed inhibitory
effects for Cyp1A, 2D














SE, SW Increased intake of cassava
leaves in diet decreases the
risk of metabolic syndrome
in Type-2 diabetic patients
(Mvitu Muaka et al., 2010)§
Antioxidant effects of the
aqueous extract of the leaves
(Tsumbu et al., 2011)§
Arthritis, Gonorrhea,
Burns, Ulcer








Carotene (Bayoumi et al.,
Although intake of a
cassava tuber rich diet
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(Yessoufou et al., 2006;
Manwa et al., 2010) Risk
of toxic effects on




















10 ml/kg of the fruit juice
extract to STZ-induced
diabetic rats for 10wks
decreased blood glucose
levels and increased plasma
insulin levels and the
number of insulin positive
islet cells. There was
decreased glucose uptake by
the brush border vessicles of
the jejunum in extract
treated rats compared to
control. In vitro, 5 μg/ml of
the extract increased glucose
transport into L6 myotubes
(Ahmed et al., 2004) Several
clinical studies in type-2
diabetic patients given
extracts of the plant
produced hypoglycaemic










































Aqueous extract of the
leaves inhibited GST
enzyme in both rat and
human liver cytosols
and recombinant GSTs;
as well as the activity of
Cyp 2C9 supersomes
but not Cyp 1A2, 2D6
and 3A4 (Appiah-Opong










Bitter melon Ebe isiugwu
(Bi)






SS 500 mg/kg aqueous leaf
extract decreased blood
glucose levels in normal, high
glucose fed and alloxan-
induced diabetic rats
(Osinubi et al., 2008)
Antioxidant effects
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SW Aqueous extract of the roots
did not show any inhibition
against pancreatic alpha
amylase and lipase enzymes



























coumarin (Patnam et al.,
2005); Loliolide
(Neergaard et al., 2010);
Stigmasterol,
9-Hexacosene (Githinji et
al., 2011); α and β-amyrin







SW 300 mg/kg of a mixture of
the aqueous fruit extract
alongside that of Coccinia
indica decreased blood
glucose levels in alloxan-
induced diabetic rats (Kumar
and Verma, 2011)§
Administration of 2 ml/kg of
the fruit juice extract twice a
day to STZ-induced diabetic
rats for twenty days resulted
in a significant decrease in
fasting blood glucose levels
by the 5th day post
administration (Nayak et al.,
2011)§ Antioxidant effects for
the methanol extract of roots
and ethyl acetate extract of
plant (Zin et al., 2002)§
Administration of 1ml/
150mg body weight of
Tahitian noni juices for
4 weeks resulted in a
prophylactic action against
alloxan-induced diabetes in


























100 mg/kg in STZ-
induced diabetic










al., 2000); Citrofolinin A















Proxeronine (Wang et al.,







Risk of liver injury/
hepatitis (Millonig et al.,
2005; Yüce et al., 2006;
Mrzljak et al., 2013)
Noni juice extract






the activity of uridine
diphosphoglucuronosyl
transferase (UGT)
enzyme of rat liver
hepatocytes both
In vitro and ex vivo
(Mahfoudh et al., 2009)
Co-incubation of noni
juice and digoxin in
Caco-2 monolayers did
not change the net
digoxin flux indicating
no modulation of P-gp
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Rubiaceae Brimstone tree Oruwo (Y),
Eze ogwu (I)
NC, SW Administration of the
methanol extract of the
leaves produced a dose
dependent (50-400mg/kg)
decrease in plasma glucose
levels in both normal and
STZ-induced diabetic rats











Decoction Ursolic acid, Oleanolic acid









Oruwal (Lawal et al., 2012)
Aqueous extract dose
dependently (1-20mg/




cells (Oga et al., 2012)
Aqueous extract and





al., 2010) 0.5 mg/ml




enzyme by 470%, but






















Aqueous extract of the leaves
decreased blood glucose
levels in normal, high glucose
fed and STZ-induced diabetic
rats at doses between 100
and 300 mg/kg (Jaiswal et al.,
2009)§ 200 mg/kg of the leaf
powder improved glucose
tolerance in both normal
wistar and spontaneously
type-2 diabetic GK rats






















































of hepatic Cyt P450 and
Cyt b5 enzymes as well
as the antioxidant
enzymes GST, GPx and
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(Anwar et al., 2007)
79 Morus alba L. Moraceae White
mulberry
Alpha glucosidase inhibitory
effects of the aqueous extract
of the leaves in Caco-2 cells
(Hansawasdi and Kawabata,
2006)§ The leaf extract
showed inhibitory effects
against rat and human
dissacharidase enzymes of
the intestinal mucousa as
well as decreased post-
prandial glucose levels in
sucrose fed rats (Oku et al.,
2006)§ 400 and 600 mg/kg
ethanol extract of the leaves
decreased blood glucose
levels in STZ-induced
diabetic rats and increased
the number of β-cells in the
islets of the pancreas
(Mohammadi and Naik,
2008)§ Ingestion of the leaf
extract by KK-Ay mice as part




levels (Tanabe et al., 2011)§












Compound A (Taro et al.,
1978); Kuwanons K and L
(Nomura et al., 1983); β-
carotene, α-tocopherol
(Yen et al., 1996);
Isoquercitrin, Astragalin,
Scopolin, Skimmin,

























M (Zhang et al., 2009b)
A sodium chloride
extract of the leaves
showed an insignificant
dose dependent (2–
6 mg/ml) inhibition of
Cyp 3A4 enzyme
activity in human liver






NW, SW Methanol extract of the stem
and leaves did not
significantly decrease blood
glucose levels in normal and
alloxan-induced diabetic
rats; while chloroform
extract of the stems and
isolated constituents
decreased glucose mediated
insulin release from INS cells
(Adebajo et al., 2005)
Hypoglycaemic effect of
defatted ethanol extract of
the leaves in STZ-induced











































Methanol extract of the
leaves as well as
isolated constituents of
the plant inhibited Cyt




effects against Cyp 1A2,
2C9, 2D6 and 3A4
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(Adebajo et al., 2006); PI,










SW 250 mg/kg aqueous and
methanol extract of the root
decreased blood glucose
levels in alloxan (Adewoye et
al., 2009) and STZ-induced
diabetic rats singly and in
combination with the leaves
of Coccinia indica (Mallick et
al., 2007)§; as well as in vivo
antioxidant effects. Dose
dependent hypoglycaemic
effect of the methanol extract
of the mature fruits in
normal and STZ-induced








(Knapp et al., 1972); α-
glucan phosphorylase





et al., 1983); Sitoindoside I,







Linolenic and Oleic acids;
24-ethyllophenol (Ghosal,
1985); Irenolone,
Emenolone (Luis et al.,
1993); Leucocyanidin,
Leuco-anthocyanidin
(Lewis et al., 1999);
Polyphenol oxidase (Yang












one (Jang et al., 2002)
Polyvalent cations
present in the plant has
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200 mg/kg aqueous extract of
the leaves improved glucose
tolerance in normal and
neonatal STZ-induced
diabetic rats (Oguanobi et al.,
2012) In vitro antioxidant
effects (Akinmoladun et al.,
2010) (Awah and Verla 2010)
400 mg/kg methanol extract
of the leaves decreased blood
glucose levels in normal and
alloxan-induced diabetic rats
(Aguiyi et al., 2000) 150 ml of





blood glucose levels in
normal subjects when
preadministered to normal
subjects 45 min before an




































Nevadensin (Ola et al.,
2009)
Aqueous and ethanol
extract of the leaves
caused dose-dependent
(400–3200 mg/kg)
increase in AST and ALT
enzyme levels, markers
of hepatotoxicity






Chrysobalanaceae Mobola plum Ebere (Y) Significant blood glucose
lowering effects of 250 mg/
kg of the aqueous ethanolic
extract of the seeds in
alloxan-induced diabetic rats






























SW Diet supplementation with
the aqueous and methanolic
extract of the seeds (6 g/kg)
resulted in 460% decrease in
fasting blood glucose levels
in alloxan-induced diabetic
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SE, SS Administration of 10 mg/kg
aqueous extract of the leaves
for 8weeks decreased plasma
glucose levels of rats fed a
high-cholesterol diet (Brai et
al., 2007) Hypoglycaemic
effect of the aqueous extract
of the seeds in normal and
alloxan-induced diabetic rats
and protective effect on


























one) (Oelrichs et al., 1995)
Ethanol extract of the
leaves inhibited the




α- and β-pinene, Sabinene,
α- and β-cubebene, β-
caryophyllene, Valencene,
α-humulene, Germacrene










Eyin olobe (Y) SW Antioxidant effects of
constituents (Londhe et al.,
2008) α-amylase inhibitory
effects (Ali et al., 2006)
Aqueous extract of the seeds
and leaves showed a dose-
dependent (150-600mg/kg)
decrease in fasting blood
glucose levels of normal rats
(Adeneye et al., 2006) Dose
dependent (200–1000 mg/
kg) decrease in blood sugar
levels by methanol extract in
alloxan-indued diabetic rats
(Raphael et al., 2002)§ No
evidence of a hypoglycaemic
effect was observed with
NIDDM patients taking 25 g
of the powdered extract daily
for 1 week as a substitute to
their oral hypoglycaemic






















acid B, Repandusinic acid








(Ali et al., 2006)
Aqueous and Ethanol
extracts of the aerial
parts of the plant
inhibited the activity of
Cyp3A4, 3A5 and 3A7
enzyme supersomes
(Agbonon et al., 2010)
Aqueous extract of the
whole plant inhibited
the activity of Cyp 1A2,
2C9, 2D6 and 3A4
plasmids as well as GST
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kg) of the methanol extract of
the leaves in normal and
alloxan-induced diabetic rats
(Okonta and Aguwa, 2007)
300 mg/kg hydro-ethanol
extract of the leaves
decreased blood glucose
levels in STZ-induced






















(Okunji et al., 2005); 10-
deoxyakuammine,
Burnamine (Shittu et al.,
2010); Coumesan






blood vessels (Fakeye et
al., 2004) Methanol
extract of the fruit rind
administered daily for
6 weeks elevated AST,











SW, SS 875 mg of a mix of extracts of
the fruit and Rauvolfia
vomitoria foliage (RC tea)
decreased serum glucose
levels in diabetes type

































In a pilot clinical study in
type-2 diabetic patients, RC
tea given daily for 4 months
decreased post prandial and
fasting plasma glucose levels
with greater effects seen in
patients with HbA1c levels









Rubiaceae African peach Ubulu inu (I) SE, NW 200 mg/kg aqueous extract of
the leaves decreased blood
glucose levels in alloxan-
induced diabetic rats but not
normal rats (Gidado et al.,
2005) Anti-hyperglycaemic
effect of 200 mg/kg ethanol
extract of the leaves
preadministered to rats prior
to the oral or intraperitoneal
administration of 2 g/kg
glucose and alpha
glucosidase inhibitory effects
(Gidado et al., 2012)
Hypoglycaemic effect in
alloxan-induced diabetic rats
and icreased activity of
glucose metabolising
enzymes (Iwueke and
Nwodo, 2008) In vitro





























pyranose, α- and β-D-






which could in turn
affect the bio-
availability of highly
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(Abreu et al., 2001);
Betulinic acid (Yinusa et
al., 2012)










NC Administration of the
aqueous extract of the leaves
for 45 days produced a dose
dependent (150–450 mg/kg)
decrease in glucose levels



















1986); Scoparic acid A, B
and C, Scopadulcic acid A
and B (Hayashi et al., 1988)
200 mg/kg aqueous extract of
the whole plant also
produced a hypoglycaemic
effect in STZ-induced diabetic
rats, increased plasma insulin
levels and protected against
diabetes induced oxidative
stress (Latha and Pari, 2004;
Latha et al., 2004)§ A
flavonoid rich fraction of the
aqueous extract of the aerial
plant increased glucose
uptake in cells possibly by
increasing expression and
translocation of the GLUT4
receptor (Beh et al., 2010)§





















flavone) (Osei-Safo et al.,
2009); Luteolin,
P-coumarin, Apigenin,
Quercetin (Beh et al.,
2010); Dulcinodal,
Dulcinodiol, Scopadiol














SW, NE, SE An extract of the root in
buffer solution produced
slight inhibition of α-amylase
activity in-vitro (Funke and
Melzig, 2006) Dose-
dependent (50–800 mg/kg)
hypoglycaemic effect of the
aqueous root bark extract in
normal and STZ-induced






























rats administered 2 mg/
kg aqueous extract
intra-peritoneally for 14
days (Dapar et al., 2007)
Elevated levels of serum
alkaline and acid
phosphatase levels as
well as decreased levels
of antioxidant enzymes
such as GSH and SOD in
the liver and kidney
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et al., 2006); Methyl
salicylate, α- and β-pinene,
1,8-cineole, α-cadinol,
p-cymene, ethyl salicylate







Sinapic acid (Meyer et al.,
2008); Securidacaside A














Ailu (Y) SW In vitro antioxidant effects









Maceration Alpha tocopherol (Mensah










and Salicylic acids (Nowak
and Kawka, 1998)








SW De-fatted methanol extract of
the leaves gave a slight dose-
dependent (100–400 mg/kg)
decrease in blood glucose
levels in STZ-induced
diabetic rats but not in




































extract of the leaves
showed 470%
inhibition of GST
enzymes in human and
rat liver cytosols and
recombinant GSTs; as
well as inhibited Cyp
1A2, 2D6 and 3A4
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emodin and its 8-O-β-
glucoside, Chrysophanol,





(Hennebelle et al., 2009);
Naringin, Apigenin
(Okpuzor et al., 2009)
In vitro antioxidant effects










NW, SW Incorporation of the dry
leaves 6.25% by weight into
the diet of STZ-induced
diabetic mice did not
produce any hypoglycaemic
effect after 9 days of
treatment (Swanston-Flatt et
al., 1989)§ Hypoglycaemic
effect of 200 mg/kg aqueous
extract of the leaves was
observed in both normal and
alloxan-induced diabetic rats,
as well as partial restoration
of the islet cells of the












































(Yadav et al., 2010)
Ingestion of the seeds
(beans) has been shown
to cause acute hepato-
myoencephalopathy in
children and is also
known to be toxic to
animals (Vashishtha et














Runfu (H) 200 mg/kg aqueous extract of
the leaves decreased blood
glucose levels by 53% in
alloxan-induced diabetic rats
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identified in the plant
Interaction/toxicity
studies











Solanaceae Garden egg Osun (Y),
Anara (I)
SE, SW The root and fruit extracts
(200 mg/kg) decreased blood
glucose levels in both normal
and STZ-induced diabetic
rats. In addition, the fruit
extract decreased weekly
food consumption
(Musabayane et al., 2006)
Administration of 50 g of the
leaves to normal volunteers
prior to an oral glucose
tolerance test produced a
decrease in blood glucose













































SW, SS in vivo antioxidant effects
(Sudheesh et al., 1999) Low
α-amylase but high α-
glucosidase inhibitory effects
and In vitro antioxidant











Solanidine (Keeler et al.,
1990); Delphinidin
(Nagase et al., 1998); α-
solasoline, α-solamargine





on drug transport due
to interaction with
multi-drug resistant
protein such as P-gp









SW In vitro protein glycation
inhibitory effects (Farrar et
al., 2008)§ Alpha amylase and
α-glucosidase inhibitors
(Kim et al., 2011)§ 250 mg/kg
sorghum extract decreased
serum glucose and increased
serum insulin levels in
diabetic but not normal rats
(Chung et al., 2011)§ In vitro
antioxidant effects (Afify et
al., 2012) Improved insulin
sensitivity due to increased
expression of PPARγ
receptors in rats fed a high
fat diet followed by 0.5% and
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SW, SE In vitro (Nia et al., 2004) and
in vivo antioxidant effects
(Olorunnisola and Afolayan,
2013) Ethanol extract of the
root decreased blood glucose
levels in normal high glucose
fed and alloxan-induced
diabetic rabbits (Mbaka et al.,
2009) Pre-administration of
the aqueous extract of the
roots for 7 days before
induction of diabetes with
alloxan had a protective
effect against elevated sugar
level and β-cell degeneration

















(Raji et al., 2006);
Columbin, Isocolumbin,





Extract of the leaves
decreased the elevated
levels of liver AST, ALT
and ASP enzymes as
well as increased GSH











SW Hypoglycaemic effect of the
methanol extract (1g/kg) of
the leaves and its chloroform
fraction was observed in
glucose loaded (2 g/kg) and
alloxan-induced diabetic rats
(Fred-Jaiyesimi et al., 2009b)
In vitro antioxidant effects








Leaves, Fruit Decoction Geraniin, Galloyl geranin,
Chlorogenic acid, 2-O-
caffeoylhydroxycitric acid








salicylic acid (Corthout et
al., 1994); Anacardic acid














750 mg/kg aqueous extract
decreased blood glucose
levels in normal and alloxan-
induced diabetic rats (Isah et
al., 2007) 250 mg/kg of a
herbal mixture (Okudiabets)
made up of bark of Alstonia
congensis, aerial parts of
Stachytarpheta angustifolia
and fruits of Xylopia
aethiopica administered for
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(Ogbonnia et al., 2010) In-
vitro antioxidant effects















Administration of 2 mg and
5 mg of various extracts of
the plant produced a dose
dependent decrease in blood
glucose levels in normal




























SW, NW The hypoglycaemic effect of
the butanol fraction of the
aqueous extract of the leaves
decreased blood glucose
levels in normal and alloxan-
























terpineol, Linalool, α and β
caryophyllene, α-cadinol,
(Noudogbessi et al., 2008)
Arabinogalactan-type
pectic polysaccharides










NW In vitro (Siddhuraju, 2007)
and in vivo antioxidant
effects (Bhutkar and Bhise,
2011)
800 mg/kg of the aqueous
extract of the seed
administered for 14 days
decreased blood glucose
levels and increased serum
insulin levels in STZ-induced
diabetic rats, resulting in
increased glucose
metabolism (Maiti et al.,
2005)§
An extract of the leaves in
buffer solution produced 90%
inhibition of α-amylase






































(Jain et al., 2007); Lupeol,
100 and 200 mg/kg












fruit extract of tamarind
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identified in the plant
Interaction/toxicity
studies















SW, SE An infusion of the leaves
parasitic on citrus limon and
Psidium guajava at a dose of
1.32mg//kg decreased blood
glucose levels in normal and
STZ-induced diabetic rats,
but not that parasitic on
Jatropha curcas (Obatomi et
al., 1994) The blood glucose
lowering effects of the
methanol extract of the
leaves was observed in
alloxan-induced diabetic
rats; an effect dependent on
host plant and time of
collection (Osadebe et al.,
2004, 2010) In vitro
antioxidant effects











































250 mg/kg ethanol extract of
the leaves decreased blood
glucose levels in normal and
alloxan-induced diabetic
rats; while 100 mg/kg
ethanol extract of the seed
decreased glucose levels in
alloxan-induced but not in
normal or glucose-loaded

















MAP 2, MAP 4, MAP 11,
MAP 28 (Caili et al., 2006)
Co-administration of




(Eseyin et al., 2007b)
Alpha glucosidase and α-
amylase inhibitory effects of
the hydro-ethanolic extract
of the leaves as well as
Antioxidant effects (Oboh et
al., 2012b)
50 mg/kg globulin proteins
extracted from the seeds
decreased blood glucose
levels when pre-
administered to normal high










SE, SS, SW Methanol extract of the
leaves decreased blood
glucose levels in alloxan
induced diabetic mice by 59%









Maceration Terminolic acid, β-
sitosterol, β-sitosteryl
palmitate (Idemudia,
1970); Terflavin A and B,
Tercatain, Tergallagin,
Potential hepatic
toxicity with high doses
due to Punicalagin and
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identified in the plant
Interaction/toxicity
studies
Varying doses (40–78 mg/kg)
of the aqueous, methanol and
petroleum ether extracts of
the fruits administered for
3 weeks also produced a
hypoglycaemic effect in
alloxan induced diabetic rats
as well as regenerated the










(Lin et al., 2000a);
Cyanidin-3-glucoside,
Gallic acid, Ellagic acid,
Brevifolin carboxylic acid,
Euginic acid (Nagappa et
al., 2003); Ursolic acid,












800 mg/kg aqueous extract of
the fruit produced a
hypoglycaemic effect in
normal and STZ-induced
diabetic rats (Ojewole and
Adewunmi, 2004) Aqueous
extract of the fruit showed
good antioxidant effects,
moderate lipase inhibitory
effects and little or no α-
amylase inhibitory effects






















(Ngassoum et al., 2001)
Ethanol extract of the
leaves given to rabbits
for 10 days (50–150 mg/
kg) increased serum ALT




Moraceae Breadfruit Ukwa (I),
Afon (Y)
SW Fractions of the hydro aceton
extract of the bark decreased
blood glucose levels at a dose
of 10 mg/kg in alloxan-
induced diabetic rats but not
normal rats (Oyelola et al.,
2007) Hypoglycemic effect of
500 mg/kg aqueous extract of
the leaves in normal fasted
glucose-loaded and STZ-
induced diabetic rats












(Aboaba et al., 2007) ;
Phyllocoumarin, 6,9-
dihydroxy megastigmane-
3-one, Catechin (Kuete et






(Mueno et al., 2008)






SW Fasting blood glucose
lowering effects of 200 mg/
kg of the aqueous root
extracts in normal rabbits
(Omonkhua and Onoagbe,
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(Morelli et al., 2006);
Syringic acid, Gluco-
syringic acid, Salicylic acid,
Protocatechuic acid and its





Diisobutyl phthalate (Lu et
al., 2009); Ceplignan-4-O-
β-D-glucoside, Urenoside A










80 mg/kg aqueous extract of
the leaves produced a dose
dependent decrease in blood
glucose levels in normal and
alloxan-induced diabetic
rabbits (Akah and Okafor,
1992); Antioxidant effects
(Igile et al., 1994; Fasakin et
al., 2011); Chronic intake of
400 mg/kg ethanolic extract
of the fresh leaves
significantly decreased
fasting blood glucose levels,
increased serum and
pancreatic insulin levels,
increased the activity of liver
antioxidant enzymes as well
as increased the expression
and distribution of Glut
4 receptors in STZ-induced
diabetic rats (Ong et al.,
2011)§; 150 ml of a (1:1:1)





glucose levels in normal
subjects when
preadministered to normal
subjects 45 min before an










(Kupchan et al., 1969);
Vernodalol, 11,13-
dihydrovernodalin
(Ganjian et al., 1983);
Vernonioside A1, A2, A3,
A4 and its aglycone, B1, B2
and B3 (Jisaka et al., 1993);
Luteolin, Luteolin 7-O-
glucoside and 7-O-
glucuronide (Igile et al.,
1994); Vernonioside D and
E (Igile et al., 1995);







Aqueous extract of the
leaves inhibited P-gp
efflux activity in Caco-2











NW Graded doses (200, 400 and
600 mg/kg) of the extract
produced significant blood
glucose reduction to control
levels 6 h after
administration in alloxan-
induced hyperglycaemic rats













(Kuroki and Conn, 1989);
Xymenynic acid, Tariric
acid (Fatope et al., 2000);
Ximonicaine, Stigmastane





Aqueous extract of the
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identified in the plant
Interaction/toxicity
studies























(Le et al., 2012)
efflux in Caco-2 cells











Administration of 1 g/kg of a
1:1 mixture of a
hydroethanolic extract of
Alstonia congensis bark and
Xylopia aethiopica fruits
decreased blood glucose
levels in normal mice
(Ogbonnia et al., 2008a);
250 mg/kg of a herbal
mixture Okudiabets) made
up of bark of Alstonia
congensis, aerial parts of
Stachytarpheta angustifolia
and fruits of Xylopia
aethiopica administered for
30 days had a marked
hypoglycaemic effect in
alloxan-induced diabetic rats
(Ogbonnia et al., 2010);
Potent inhibitory effects
against pancreatic lipase, α-
amylase and α-glucosidase
enzymes; Antioxidant effects
(Etoundi et al., 2010;








Fruit, Seeds Xylopic acid (15β-
acetoxy kaur-16-en-19-




acid (Leboeuf et al.,
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Cannabisin B and D
(Lajide et al., 1995); 7α-
hydroxy trachyloban-
19β-oic acid (Ngouela et
al., 1998)
114 Zea mays L. Poaceae Corn Maize Agbado (Y),
Oka (I),
Masara (H)
SW 0.2 g/d aqueous extract of
corn silk improved kidney
parameters in STZ-induced
diabetic rats but no
significant hypoglycaemic
effect (Suzuki et al., 2005);
100 mg/L ethanol extract of
the corn silk showed PPARα
and γ agonist activities (Rau
et al., 2006)§; Inhibitory
effects of the aqueous and
ethanol extract of the maize
kernels on α-glucosidase
enzymes and antioxidant






Seed silk Decoction Chrysoeriol 6-C-β-boivino
pyranosyl-7-O-β-gluco
pyranoside, Alternanthin
(Suzuki et al., 2003)
Glucose yield and
glycaemic index of
maize starch has been
shown to be high,
which may pose a
problem for diabetic





Zingiberaceae Ginger Atale (Y),
Jinga (I), Chita
(H)




in normal and STZ-induced
diabetic rats (Ojewole, 2006);
Alpha amylase and Alpha
glucosidase inhibitory effects
and In vitro antioxidant
effects (Oboh et al., 2010);
in vivo antioxidant effects





























phenyl) methanol (Kato et
al., 2006); Zingerone,
Geraniol (Chen et al.,




Shogaols, Paradols and its
derivatives, Zingiberene,
Curcumene, β-bisabolene,




Terpineol (Ali et al., 2008;
Kubra and Rao, 2011)
Insufficient evidence for
a possible interaction
with warfarin or CYPs









(Nabekura et al., 2005)
n Bi-Bini, Ef-Efik, Es-Esan, F-Fulani, H-Hausa, I-Ibo, Ib-Ibibio, Id-Idoma, Ig-Igala, Ige-Igede, Ij-Ijaw, Nu-Nupe, Ti-Tiv, and Y-Yoruba.
# NC¼North central, NE¼North east, NW¼North west, SE¼South east, SS¼South south, and SW¼South west.














other in vivo models used include spontaneous diabetic animal
models obtained as a result of one or more genetic mutations such
as obese zucker fatty rats, db/db mice and KK-Ay mice; as well as
the use of high glucose or fructose-fed animals. This latter group
simulate the development of diabetes from insulin resistance
better as is more commonly found in patients with type-2 diabetes
(Srinivasan and Ramarao, 2007).
Although most plants were only evaluated experimentally in a
type-1 diabetes model, some of these have been shown to be
effective hypoglycemic agents in type-2 diabetes patients, such as
extracts of Bridelia ferruginea Benth. Daily administration of 15 mg
of the leaves as an infusion to type-2 diabetic patients previously
on insulin injections for eight weeks resulted in a significant
decrease in their blood sugar levels (Iwu, 1983).
Only two out of the 96 plant species were ineffective in the
in vivo experimental model of study, namely Zea mays L. (Suzuki
et al., 2005) and Cucumeropsis mannii Naudin (Teugwa et al.).
Despite its identified in in vitro PPARα and γ agonist activities
and α-glucosidase inhibitory effects (Lee et al., 2010), extracts of
Zea mays failed to produce a significant hypoglycemic effect
in vivo (Rau et al., 2006). This could possibly be as a result of the
absence of the bioactive constituent(s) responsible for the
hypoglycemic effect in the sample used for the in vivo study.
The absence of an in-vivo hypoglycemic effect would however
not ‘eliminate’ its use in the clinical management of diabetes,
which also takes into account co-morbid conditions. In this
regard, Zea mays could also provide protection against diabetic
nephropathy, as it has been shown to improve kidney para-
meters in vivo (Suzuki et al., 2005).
In the case of Cucumeropsis mannii, its traditional use involves
the ingestion of its ashes or its juice (Gbolade, 2009). This may
indicate that its use is based on its oligo-elements and/or vitamins.
In fact the supplementation of elements such as chromium,
magnesium and vanadium is actively explored in the treatment
of diabetes (Anderson et al., 1997; Halberstam et al., 1996;
Rodríguez-Morán and Guerrero-Romero, 2003); some of which
have been identified in the seeds of Cucumeropsis mannii (Badifu
and Ogunsua, 1991).
3.2. In vitro pharmacological evidence
It is recommended that in vitro experiments are carried out to
ascertain the mechanism of action for the plant. Certain plants
produce their hypoglycemic effects as a side effect of their in vivo
toxicity (Marles and Farnsworth, 1995). There is also the risk that
the hypoglycemic effect is being mediated – at least in part –
through an unwanted physical mechanism, rather than a physio-
logical one, such as was observed with Gymnema sylvestre (Retz.)
R. Br. Ex Sm (Persaud et al., 1999). This immediately eliminates the
potential use of such a plant as a therapeutic hypoglycemic
agent. In addition, due to the ethical considerations surrounding
animal use (Festing and Wilkinson, 2007), it is advised that
validation experiments are ‘replaced’ with non-animal models
where possible.
Over one-third of the plants in our review have been studied
for in vitro in models that could possibly explain some or all of
their mechanism of action. Twenty-nine plants have inhibitory
effects against either α-amylase or α-glucosidase enzymes; five
plants have agonist activity on the PPARγ receptor, whose activa-
tion enhances glucose metabolism; four plants increase insulin
release from pancreatic cells; five plants increase glucose uptake
in muscles or liver; while two plants increased the expression of
the glucose transporter GLUT4, which in turn increases glucose
uptake into muscles and adipose tissues. Two plants were identi-
fied as potential DPP-IV inhibitors, while six plants were identified
as aldose reductase inhibitors (Fig. 1).
In vitro experiments are often designed to ‘reflect’ the mechanism
of existing drugs used in diabetes management. Plants that possess
alpha amylase or alpha glucosidase inhibitory effects reflect the
action of acarbose, PPARγ agonist activity reflect the thiazolidine-
diones, while aldose reductase inhibitors are potential agents for
preventing diabetic complications like the drug epalrestat. Thus with
this identified mechanisms, researchers and healthcare professional
alike can immediately identify the potential therapeutic benefit of
the plant. This information could contribute to a more rational
therapeutic regimen for diabetes patients, possibly benefitting from
a synergistic effect with herbal remedies.







































































Fig. 1. Proposed molecular mechanisms of hypoglycemic effects for species studied so far.
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The disadvantage of the molecular approach for experimental
validation of plant activity is that the biological assays only explore
known targets and do not take into account extracts that might be
acting on unknown targets, possibly through innovative mechan-
isms. In addition, herbal medicines are often complex mixtures
of various phytochemicals which work synergistically to achieve a
desired therapeutic outcome (Campbell-Tofte et al., 2012). In such
cases, a single end-point in vitro biological assay will not be
sufficient in evaluating the clinical effect of the plant. For
instance, the methanol extract of the root and stem of Gongronema
latifolium Benth. produced a greater anti-hyperglycemic effect in
glucose loaded rats than each of its fractions, indicating a syner-
gistic effect of its constituents possibly acting through different
molecular mechanisms (Adebajo et al., 2013).
There is also a holistic approach in the herbal management of
diabetes such that plants which are not hypoglycemic themselves
may be included in multi-component preparations because of
their benefits in co-morbid conditions. Thus, in vitro studies might
not immediately indicate the beneficial effect of the plant. A good
example is the use of the aphrodisiac plant Mondia whiteii (Hook.
f.) Skeels (Quasie et al., 2010). Despite not showing in vitro
hypoglycemic effect (Etoundi et al., 2010), it is commonly included
in multi-component preparations for diabetes management in
men since erectile dysfunction is a common complication of the
illness (personal communication during field work). This however
does not preclude any in vivo activity which is yet to be evaluated.
3.3. Bioactive compounds
Over forty compounds from twenty three of the reviewed
plants have been identified, either through an activity guided
fractionation or in silico studies as the bioactive constituents
responsible for some or all of the plants' beneficial effects in
diabetes. Some of these constituents are species-specific such as
the alkaloid mahanimbine from Murraya koenigii (L.) Spreng
(Dineshkumar et al., 2010), while others are known to be present
in many plants like the alkaloid trigonelline, which is responsible
for the hypoglycemic effect of Abrus precatorius L. (Monago and
Nwodo, 2010) and Trigonella foenum-graecum L. (fenugreek), a
plant whose use in diabetes management is popular across India
and Europe (Bailey and Day, 1989). We hereby classify these
compounds according to similar chemical features (which may
not necessarily refer to similar biosynthetic pathways) as follows:
compounds containing nitrogen (1–9) (Fig. 2), terpenes (10–16)
(Fig. 3), phenolic compounds (17–33) (Figs. 4 and 5), and com-
pounds containing hydroxyl groups including sugars (34–40)
(Fig. 6).
3.3.1. Nitrogen containing compounds
A number of alkaloidal and non-alkaloidal active principles
from plants used in diabetes management have been reported.
Some of these were isolated from samples not collected from
Nigeria such as hypoglycin A (1) and B (2) – from the fruit of
Blighia sapida K.D.Koenig. (Chen et al., 1957). Murraya koenigii
leaves are also used traditionally in Indian Ayurvedic system to
treat diabetes. Mahanimbine (5) isolated from the Indian plant
samples decreased blood glucose levels in STZ-induced diabetic
rats and also produced a dose-dependent α-amylase and
α-glucosidase inhibitory effect (Dineshkumar et al., 2010). Its
cellular mechanism of action is also thought to be mediated by
an increase in glucose utilization (Dinesh Kumar et al., 2013).
Paradoxically, this and other related carbazole alkaloids isolated
Trigonelline (4) 
Abrus precatorius










S-allylcysteine sulfoxide (9) 
Allium sativum
S-allylcysteine sulfoxide (8) 
Fig. 2. Nitrogen containing compounds with beneficial effects in diabetes.
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Fig. 3. Terpenes with beneficial effects in diabetes.
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Zingiber officinale
Fig. 4. Phenolic compounds with beneficial effects in diabetes.
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from plant samples from Nigeria decreased the glucose-mediated
insulin release from INS-1 cells when compared to control, even
though the amount of glucose released was dose dependent.
This effect may however be explained by their known in vitro
cytotoxicity (Adebajo et al., 2005).
The alkaloid trigonelline (4) isolated from the seeds of Abrus
precatorius (L.) collected from the eastern part of Nigeria decreased
blood glucose levels in alloxan-induced diabetic rats as well
as reduced the activity of glucose-6-phosphatase and glycogen
phosphorylase, two enzymes important for glucose production
(Monago and Nwodo, 2010). Akuammicine (3) isolated from the
chloroform extract of the seeds of Picralima nitida (Stapf) T.Durand
and H.Durand stimulated glucose uptake in 3T3-L1 adipocytes
(Shittu et al., 2010). It is also present in plants of the genus Alstonia
such as Alstonia boonei De Wild. and Alstonia Congensis Engl. and
would most likely be contributing to their blood glucose lowering
activity. Ajmaline (6) and isosandwichine (7) from Rauvolfia
vomitoria Afzel. were identified as DPP-IV inhibitors using an in
silico approach (Guasch et al., 2012).
Garlic and onions are commonly used as part of the diet in
many Nigerian households and the hypoglycemic effect of
plant samples collected from Nigeria has also been studied
(Eyo et al., 2011). This hypoglycemic effect is possibly due to the
presence of S-methylcysteine sulfoxide (8) (SMCS) in onions
and S-allylcysteine sulfoxide (9) (SACS) in garlic, which have
been isolated from Indian plant samples and have been shown
to improve glucose tolerance in alloxan-induced diabetic rats
(Sheela et al., 1995). Clinical studies in humans have shown that
the supplementation of garlic to diabetic patients in combination
with hypoglycemic drugs improves glycemic control in addition to
Kaempferol gentiobioside (31) 






Rutin (29) & 
Quercetin (30) 
Bauhinia monandra
Fig. 5. Phenolic compounds (flavonoids) with beneficial effects in diabetes.
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Fig. 6. Other hydroxylated compounds with beneficial effects in diabetes.
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the reduction of cardiovascular risk (Sobenin et al., 2008).
Although they both contain nitrogen, SMCS and SACS are primarily
classed as sulfur containing compounds.
3.3.2. Terpenes
A number of terpenes have been isolated as bioactive consti-
tuents in plants used for diabetes management (Fig. 3). The leaves
of Gongronema latifolium, otherwise known as ‘utazi’ or ‘madu-
maro’ in Ibo and Yoruba respectively is commonly used as a food
vegetable and is widely recognized for its traditional use in
diabetes management. Lupenyl cinnamate (15), lupenyl acetate
and α- and β-amyrin cinnamates (16) isolated from the combined
root and stems of locally obtained samples have recently been
identified as the bioactive compounds, possessing both anti-
hyperglycemic effects in glucose-fasted rats as well as insulin
stimulating effects in INS-1 cells (Adebajo et al., 2013).
Foetidin from the whole plant and the unripe fruits of Momor-
dica foetida collected in Nigeria also decreased blood glucose levels
of normal fasted, but not alloxan-induced rats at only 1 mg/kg
(Marquis et al., 1977). Acetylenic glucosides (10) and (11) from
Bidens pilosa decreased blood glucose in the murine type 2 diabetes
model C57BL/Ks-db/dbmice (Ubillas et al., 2000), and inhibited the
spontaneous development of diabetes in non-obese diabetic
(NOD) mice by modulating the differentiation of T-helper cells
(Chang et al., 2004).
The monoterpenes myrcene (12), citral (13) and geraniol (14)
found in Cymbopogon citratus were identified as aldose reductase
inhibitors using in-silico docking methods (Vyshali et al., 2011).
They are also components of the essential oil of many medicinal
plants used in Nigeria as shown in Table 1. This preliminary
information warrants further in vitro and in vivo studies involving
plant samples from Nigeria previously shown to contain these
compounds, given that the beneficial effect of the essential oil of
Cymbopogon citratus containing high amounts of these monoter-
penes has now been validated in vivo in experimentally induced
type-2 diabetic rats (Bharti et al., 2013).
3.3.3. Phenolic compounds
A wide range of phenolic compounds have been identified
as active principle(s) in some of the plants here reviewed.
Anthraquinone glycosides from Morinda citrifolia L, namely dam-
nacanthol-3-O-β-D-primeveroside (18) and lucidin 3-O-β-D-prime-
veroside (19), decreased blood glucose levels in STZ-induced
diabetic mice at 100 mg/kg (Kamiya et al., 2008). Incidentally, this
plant is not native to Nigeria and is not known to grow in Nigeria.
However, the use of a registered herbal product of the juice
extract, Tahitian noni juices (TNJ) is quite popular in Nigeria for
various ailments including diabetes. Administration of 1 ml/
150 mg body weight of the rats twice daily for four weeks prior
to and after the induction of diabetes with alloxan resulted in
significant decrease in blood sugar levels, indicating a prophylactic
effect of the extract against alloxan-induced diabetes (Horsfal et
al., 2008). The presence of these phenolic compounds in the
marketed product has however not been confirmed.
Kolaviron (17) is a mixture of flavanones isolated from the
acetone extract of the edible nuts of Garcinia kola Heckel (bitter
kola), which is valued in most parts of West Africa. It decreased
blood sugar levels in normal and alloxan induced diabetic mice at
a dose of 100 mg/kg, as well as inhibited rat lens aldose reductase
(RLAR) activity (Iwu et al., 1990a).
Other phenolic compounds have been identified as bioactive
constituents but not from plant samples collected in Nigeria.
A diacylated anthocyanin peonidin 3-O-[2-O-(6-O-E-feruloyl-β-
D-glucopyranosyl)-6-O-E-caffeoyl-β-D-glucopyranoside]-5-O-β-D-
glucopyranoside isolated from the root of Ipomoea batatas (L.) Poir.
showed potent maltase inhibitory effects in vivo (Matsui et al.,
2002), while ellagic acid (26) and 3,5-dicaffeoylquinic acid (27)
isolated from the hot water extract of the leaves showed potent
aldose reductase inhibitory effects (Terashima et al., 1991). Law-
sone (20) (a naphtoquinone) and gallic acid (21) isolated from the
ethanol extract of the aerial parts of Lawsonia inermis L. inhibited
the formation of advanced glycated end products in vitro (Sultana
et al., 2009). Some methoxy phenyl derivatives (22–25) isolated
from the rhizomes of Zingiber officinale Roscoe have been identi-
fied as aldose reductase inhibitors both in vitro and in vivo,
suppressing sorbitol accumulation in human erythrocytes as well
as lens galactitol accumulation in 30% galactose-fed rats (Kato
et al., 2006).
Several isolated flavonoids have also been identified as bioac-
tive constituents. Isoscutellarein (8-hydroxy apigenin) (28) is a
flavonoid isolated from the hot water extract of the leaves of Bixa
orellana L., which was identified as an aldose reductase inhibitor
(Terashima et al., 1991). Rutin (29) and quercetin (30) were
isolated from the leaves of Bauhinia monandra Kurz as the anti-
hyperglycemic constituents in alloxan-induced diabetic rats (Alade
et al., 2011, 2012). A bioassay guided fractionation of the stem bark
of Cassia fistula L. led to the identification of catechin (33) as the
bioactive agent. It decreased plasma glucose levels in STZ-induced
diabetic rats, with direct effects on glucose metabolizing enzymes
and expression of the glucose transporter GLUT4 (Daisy et al.,
2010). Fractionation of the methanol extract of the leaves of Senna
alata (L.) Roxb. (syn- Cassia alata), which showed potent α-
glucosidase inhibitory effects, identified kaempferol gentiobioside
(31) and kaempferol (32) as the bioactive compounds (Varghese et
al., 2013). Increased translocation of GLUT4 receptors to the
plasma membrane of L6 myotubes was also observed with a
flavonoid-rich fraction of Scoparia dulcis L. (Beh et al., 2010),
although the bioactive constituent(s) was not identified.
The presence of aromatic hydroxyl groups in the benzo-γ-
pyran structure of flavonoids is associated with its antioxidant
properties, particularly its free radical scavenging effects. These
properties have been shown to protect pancreatic islet cells from
oxidative stress as well as help in the regeneration of β-cells as
shown with epicatechin found in green tea (Sabu et al., 2002) and
quercetin (Coskun et al., 2005). More importantly, they can
prevent the formation of advanced glycated end products (AGEs)
and other diabetic complications associated with high oxidative
stress conditions such as artherosclerosis, nephropathy, neuropa-
thy, retinopathy and erectile dysfunction (Rahimi et al., 2005).
Thus, the presence of quercetin and epicatechin as well as other
potent antioxidant flavonoids in a wide range of plants such as
Irvingia gabonensis, Khaya senegalensis, Mangifera indica, Securi-
daca longipedunculata and Ocimum gratissimum, will contribute to
– and in some cases may be the basis for – their use in the holistic
management of diabetes which includes the prevention of diabetic
complications.
Other flavonoids have also been shown to directly affect
specific therapeutic targets in diabetes. For instance, supplemen-
tation of mice diet with naringin or hesperidin modulated the
activity of glucose metabolizing enzymes, with an increase in
hepatic glucokinase activity and decrease in hepatic glucose-6-
phosphatase activity in diabetic db/db mice (Jung et al., 2004) and
GK type-2 diabetic rats (Akiyama et al., 2009). These two flavo-
noids are constituents of all citrus fruits and have also been
identified in Senna alata (Hennebelle et al., 2009) and Rauvolfia
vomitoria (Campbell-Tofte et al., 2011) and as such may account for
some of their effects. Myricetin is another flavonoid that has
shown direct beneficial effects in diabetes through enhanced
glycogen metabolism (Ong and Khoo, 2000) and improved insulin
sensitivity (Liu et al., 2007). It has been identified in some of the
plants either in its aglycone form or as a glycoside. These are the
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Allium species, Aloe vera, Azadirachta indica, Citrus species, Carica
papaya, Bryophyllum pinnatum, Cassia sieberiana, Chrysophyllum
albidum, Ipomoea batatas and Bridelia ferruginea.
3.3.4. Hydroxylated compounds including sugars
Some other non-phenolic hydroxylated cyclic compounds have
been isolated and identified as bioactive agents. These include the
gingerols (34–36) from Zingiber officinale, which were shown to
enhance glucose uptake into muscles as a result of a direct
increase in the expression of the GLUT4 receptor (Li et al., 2012).
An inositol derivative, D-3-O-methyl chiroinositol (37) isolated
from the methanol extract of the stem bark of Bauhinia thonningii
Schum. produced a dose-dependent decrease in blood glucose
levels in alloxan-induced diabetic rats (Asuzu and Nwaehujor,
2013).
Finally, a number of benzyl derivatives including carbamates
and thiocarbamates have been isolated from fractions of the
methanol extract of the fruits of Moringa oleifera Lam. These
compounds have been shown to possess insulin secretory effects,
stimulating Z15 ng insulin/mg protein in pancreatic INS-1 cells at
100 ppm. Some of these compounds were identified as 1-O-phenyl
α-L-rhamnopyranoside (38), methyl N-{4-[(α-L-rhamnopyranosyl)
benzyl]}carbamate (39), and methyl N-{4-[(40-O-acetyl-α-L-rham-
nopyranosyl)benzyl]}carbamate (40).
Many plant secondary metabolites have been associated with
specific beneficial effects in diabetes, which might account for the
therapeutic effect of the herbal drug (Qi et al., 2010; Singh et al.,
2013). Thus, apart from a bioguided fractionation, the biologically
active agent of a plant can also be inferred by evaluating the
phytochemical constituents that have previously been isolated.
These can thereafter be confirmed in specific pharmacologic
experiments.
3.4. Clinical studies
The validation of biologically active plants in randomized,
placebo-controlled clinical trials involving human subjects is a
necessary step towards the possible integration of traditional
herbal products into health systems. For these purposes, isolation
of the active constituent may not be necessary. The European
Directive of Traditional Herbal Medicinal Products is an example of
how reports of traditional use and a sound safety profile are
enough to regulate herbal medicines (Cox and Roche, 2004).
However, knowing the identity of the active principle would be
ideal in order to ensure a better quality control and perhaps a
more defined dosage.
Fourteen of the plants reviewed in this paper have been
clinically evaluated in human subjects, either singly or in combi-
nation. These are Bridelia ferruginea, Citrus aurantium, Gongronema
latifolium, Ocimum gratissimum, Rauvolfia vomitoria, Vernonia
amygdalina, Carica papaya, Curcuma longa, Ipomoea batatas, Irvin-
gia gabonensis, Gymnema sylvestre, Phyllanthus amarus and Sola-
num aethiopicum (Table 1), of which the first six involved plant
samples collected from Nigeria. Only Phyllanthus amarus did not
produce the desired clinical effect (Moshi et al., 2001).
Most of the clinical studies were not randomized, controlled
trials but preliminary studies evaluating the therapeutic effect
of the plant in human subjects. Exceptions to these were those
carried out on Rauvolfia vomitoria and Citrus aurantium (Campbell-
Tofte et al., 2011), Irvingia gabonensis (Ngondi et al., 2009) and
Ipomoea batatas (Ludvik et al., 2004). Similarly, a meta-analysis by
Leung et al. (2009) of all clinical studies carried out on Momordica
charantia identified flaws in their study design, despite the extract
consistently producing a hypoglycemic effect. As a result,
appropriate conclusions that will act as guidelines for their clinical
use cannot be drawn.
A good knowledge of the traditional use of these plants based
on ethnobotanical studies is very important in the design of a good
clinical study. This is especially important for plants which are
used as mixtures, as the individual components may be working
synergistically to produce the overall desired effect. An example is
the synergistic effect produced by a decoction mix of the leaves
of Gongronema latifolium, Ocimum gratissimum and Vernonia
amygdalina in modulating baseline blood glucose levels, which
was not observed with the individual plants (Ejike et al., 2013).
Given that many of these herbal remedies are currently being
taken by diabetic patients alongside their prescription medicines,
a concerted effort between clinicians and researchers would be an
ideal way to recruit patients to such studies.
To ensure the reliability of conclusions drawn from any clinical
study, they should always involve proper planning with appro-
priate controls and ought to be conducted within a reasonable
time frame, in line with the guidelines of the Declaration of
Helsinki. In addition, the recommendations for reporting rando-
mized clinical trials, as defined in the ‘Consolidated Standards
of Reporting Randomized Clinical Trials (CONSORT) statement’
(Schulz et al., 2010) should also be followed. Nonetheless,
this relatively high ‘success’ rate amongst the various studies
conducted highlights the potential of harnessing ethnobotanical
information in enhancing patient therapy.
4. Toxicological evidence and considerations
The administration of whole plant extracts or fractions con-
sisting of a myriad of compounds, can elicit different biological
effects in the body, some of which may be harmful toxic effects.
Sometimes, these toxic effects are only associated with certain
parts of the plant. For example, the leaves of Senna occidentalis
have hepatoprotective effects and are used traditionally for the
treatment of liver disorders (Jafri et al., 1999). However, ingestion
of toxins found in the seeds (beans) is thought to be the probable
cause of acute hepato-myoencephalopathy (HMP) in children
(Vashishtha et al., 2009). This risk of toxicity associated with the
use of herbal products is one of the main reasons for the hesitance
amongst healthcare practitioners towards promoting their inte-
gration into healthcare systems.
Adequate knowledge about the traditional use of such plants is
very necessary as this often helps to forestall the ingestion of such
toxic plants or plant parts. Sometimes the toxic component may
have been identified such as abrin, a toxic protein found in the
seeds of Abrus pecatorius, with an estimated human fatal dose of
0.1–1 mg/kg (Kirsten et al., 2003). In rare cases, the hypoglycemic
agent in the plant could also be the toxic agent, such as with
hypoglycin from Blighia sapida (Sherratt, 1986). Thus, the thera-
peutic use of such a plants as whole extracts is therefore not
recommended.
Various plants in Table 1 have been associated with specific
organ toxicity. Examples include the nephrotoxic effects of Alstonia
congensis, Aristolochia spp., Cassia sieberiana, Ficus exasperata,
Securidaca longipedunculata and the hepatotoxic effects of Cassia
sieberiana, Ficus exasperata, Morinda citrifolia, Picralima nitida and
Senna occidentalis. The hepatotoxic effects of some extracts such as
Ocimum gratissimum and Sphenocentrum jollyanum are directly
linked to their effect on the liver function enzymes. The cardio-
toxic and neurotoxic effects of some other extracts have also been
identified. Sometimes, these toxic effects are only seen at high
doses, which would therefore not preclude their continued use
as medicinal plants so long as there is appropriate information
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about the safe dose ranges. The use of other more toxic plants
would however need to be completely discontinued.
A thorough analysis of the plant's extracts as well as identified
phytochemical constituents with respect to their safety/toxicity
profile particularly in humans can ensure a critical assessment of
its therapeutic potential. Previously, coumarins which are a
component of a wide range of plants were identified as hepato-
toxic based on various studies carried out in rodents. However,
further studies have showed that certain animal species are
resistant to coumarin-induced toxicity. The 7-hydroxylation meta-
bolic pathway is the most favored in humans leading to the
formation of non-toxic metabolites, whereas in rats the most
favored pathway is a 3,4-epoxidation leading to the formation of
toxic metabolites. Knowledge of this and a quantitative health risk
assessment have now confirmed its safety in humans (Felter et al.,
2006; Lake, 1999).
Evaluation of medicinal plants for potential herb–drug interac-
tions is equally as important as its evaluation for efficacy
and safety. Two types of herb–drug interactions exist: pharmaco-
dynamic interactions and pharmacokinetic interactions. If a herbal
plant alters the expected pharmacological effect of a drug as a
result of its biochemical or physiological effect on
the body, this is known as a ‘pharmacodynamic interaction’.
If the herb and the drug are both expected to produce the same
pharmacological effect, there may be an increased therapeutic
effect produced with their co-administration. This knowledge can
be harnessed towards producing a synergistic effect between the
two, which would possibly require a dose adjustment. Otherwise,
the resulting effect could be detrimental if appropriate monitor-
ing and evaluation is not done. A good example is the severe
hypoglycemic that was observed in a female diabetic patient
taking chlorpropamide and a meal containing Momordica char-
antia and Allium sativum (Izzo and Ernst, 2001).
A synergistic effect should however not be assumed. It is
sometimes advisable for patients not to take drugs alongside their
herbal products due to negative drug interactions that may occur.
For instance, the water soluble fraction of okra fruits has been
shown to decrease the absorption of metformin (Khatun et al.,
2011). Although both would otherwise be beneficial in diabetes
management, taken together would result in a decrease in the
therapeutic concentration of metformin, which in turn may not
bring about the desired hypoglycemic effect in the patient.
Constituents of medicinal plants also undergo the four main
pharmacokinetic processes of absorption, distribution, metabolism
and elimination (ADME). There is therefore the possibility of an
interaction with one of the different ADME parameters by the
herb, which could invariably affect the fate/bioavailability of a co-
administered drug and possibly, the resulting therapeutic benefit
(s). This is known as a ‘pharmacokinetic interaction’.
Out of the one hundred and fifteen plants reviewed in this
paper, over thirty of them have shown in vitro and/or in vivo
modulation of the activity of one or more of these ADME para-
meters (Fig. 7). Some of these interactions were on absorption,
either by modulating the effect of P-glycoprotein (P-gp), an
intestinal efflux transporter, or by direct effects on the intestinal
tight junctions. Other pharmacokinetic interactions were on
metabolism, by interacting with one or more cytochrome P450
enzymes responsible for phase 1 metabolism or either of the
phase 2 metabolic enzymes (Table 1).
The role of P-gp in the intestinal epithelium is the extrusion
of certain xenobiotics from the blood to the intestinal lumen
as well as to minimize the entry of drugs in the lumen into the
bloodstream, ultimately resulting in decreased absorption and
decreased oral bioavailability (Sharom, 2007). For drugs that are
P-gp substrates such as glibenclamide, this effect of the efflux








































Fig. 7. In vitro pharmacokinetic herb–drug interactions identified based on the literature reviewed.
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dose of the drug to ensure that an adequate therapeutic concen-
tration is achieved in the bloodstream. Co-administration of the
drug with a herb with inhibitory effects on P-gp such as Acacia
nilotica, Annona senegalensis, Bauhinia thonningii, Bridelia ferrugi-
nea, Carica papaya and Morinda lucida might result in increased
plasma concentration of the drug.
The cytochrome P450 (CYP) family of enzymes are respon-
sible for phase 1 oxidative, peroxidative and reductive metabolic
transformations of drugs, environmental chemicals and natural
compounds into less toxic, more water-soluble products, in order
to facilitate their excretion from the body. They are most abundant
in the liver, which is the primary site for metabolism. The activity
of CYP enzymes can be modified either by induction or inhibition
as seen with the extracts of Bixa orellana and Jatropha curcas
respectively. The biological activity of the xenobiotics metabolized
by these enzymes can be greatly altered as a result (Rendic and
Carlo, 1997). St John's wort (Hypericum perforatum) is a very good
example of a herbal product that has produced clinically signifi-
cant effects as a result of its interactions with P-gp and CYP
enzymes (Henderson et al., 2002).
In vitro interactions have also been identified with the phase
2 metabolizing enzymes, particularly with the glutathione trans-
ferases (GSTs). As with P-gp and CYPs, such interactions can alter
the plasma concentration and the resulting therapeutic effect of
the co-administered substrate drug. In addition, GSTs directly
control the levels of glutathione (GSH) within the cell. GSH also
acts as an antioxidant within cells, and is particularly important in
diabetic conditions characterized by oxidative stress. Unfortu-
nately, plants such as Securidaca longipedunculata which decrease
GSH levels might be counter-productive in diabetic patients.
For many of these plants in Fig. 7, the phytochemical constitu-
ents responsible for the pharmacokinetic interaction are still
unknown. Polyphenols present in plants especially flavonoids have
been the most implicated in herb–drug interactions, with direct
effects seen with specific flavonoids on P-gp and drug metaboliz-
ing enzymes (Morris and Zhang, 2006) (Galati and O'Brien, 2004)
(Hodek et al., 2002). It should however be taken into account that
many of the in vitro pharmacokinetic interactions or alarming case
studies published in primary literature fail to translate into
significant clinical risks for the patients, as seen with many herbal
remedies taken in Europe (Williamson et al., 2013). There is still an
urgent need for effective pharmacovigilance of herbal medicines
to ensure their safe and effective use in therapeutic management
(Shaw et al., 2012).
5. Conclusions
Nigeria is endowed with a biodiversity of medicinal plants,
many of which are currently used in the traditional management
of diabetes. Our review shows that there is very good preclinical
evidence for the efficacy of most of these plants, either as
hypoglycemic agents or as useful agents in the management of
diabetic complications. We have mapped their pharmacological
mechanism of action as this can serve to promote a more rational
use of these plants as herbal medicines based on the expected
therapeutic outcome and their tabulated toxicological effects. Last
but not least, we have also highlighted potential interactions with
key parameters of the ADME process that can arise from the use of
these plants in therapeutic management.
These available data can provide evidential support for the
clinical development of a number of medicinal plants as adjuvant
therapy. We believe that the criteria for selection should be based
on social acceptance/frequency of use, efficacy and toxicity profile,
and availability/sustainability of the supply chain, possibly tailored
to each region. A set of quality parameters for the standardization
of these plants as herbal preparations (such as pharmacopoeial
monographs) would be required to ensure the reproducibility of
their therapeutic effects. Finally, as a means of giving credence to
the pre-clinical experimental evidence, intervention or clinical
studies with the standardised materials should be carried out in
order to validate their usefulness in diabetes management. We
hope that in this manner the therapeutic potential of these
medicinal plants can be best harnessed, towards a possible
integration into the healthcare system.
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